PTK6
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A4FU28 | Y433 | Sugiyama | CTAGE9 | EEKLSRVEEKISHATEELETyRKLAKDLEEELERTVHFYQK |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y791 | Sugiyama | POTEF A26C1B | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPVLLTEATLN |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | Y30 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKG |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00232 | Y20 | Sugiyama | PSMD12 | _MADGGSERADGRIVKMEVDysATVDQRLPECAKLAKEGRL |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00410 | Y33 | Sugiyama | IPO5 KPNB3 RANBP5 | LLLGNLLsPDNVVRKQAEEtyENIPGQSKITFLLQAIRNTT |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00468 | Y639 | Sugiyama | AGRN AGRIN | VCPRCEHPPPGPVCGSDGVTyGsACELREAACLQQtQIEEA |
| O00469 | Y586 | Sugiyama | PLOD2 | FWFPIFSEKACDELVEEMEHyGKWSGGKHHDsRIsGGyENV |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O00499 | Y90 | Sugiyama | BIN1 AMPHL | ASVKAMHEASKKLNECLQEVyEPDWPGRDEANKIAENNDLL |
| O14744 | Y502 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | NEVRACREKDRDPEAQFEMPyVVRLHNFHQLSAPQPCFTFS |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15294 | Y316 | Sugiyama | OGT | YCNLANALKEKGSVAEAEDCyNTALRLCPTHADSLNNLANI |
| O15355 | Y405 | Sugiyama | PPM1G PPM1C | TMDGRVNGGLNLSRAIGDHFyKRNKNLPPEEQMISALPDIK |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15372 | Y350 | Sugiyama | EIF3H EIF3S3 | IKEFTAQNLGKLFMAQALQEyNN__________________ |
| O43172 | Y31 | Sugiyama | PRPF4 PRP4 | ATKTKAPDDLVAPVVKKPHIyyGsLEEKERERLAKGESGIL |
| O43172 | Y32 | Sugiyama | PRPF4 PRP4 | TKTKAPDDLVAPVVKKPHIyyGsLEEKERERLAKGESGILG |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43684 | Y141 | Sugiyama | BUB3 | KLWDPRtPCNAGTFsQPEKVytLSVSGDRLIVGTAGRRVLV |
| O43707 | T725 | Sugiyama | ACTN4 | DLLEQQHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIAR |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y727 | Sugiyama | ACTN4 | LEQQHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIARTI |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43707 | Y886 | Sugiyama | ACTN4 | ELRRELPPDQAEyCIARMAPyQGPDAVPGALDyKsFStALy |
| O43707 | Y898 | Sugiyama | ACTN4 | yCIARMAPyQGPDAVPGALDyKsFStALyGEsDL_______ |
| O43765 | Y195 | Sugiyama | SGTA SGT SGT1 | HVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGG |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y275 | Sugiyama | CALU | KDWILPsDyDHAEAEARHLVyEsDQNKDGKLTKEEIVDKyD |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y291 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDVMFGG |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60506 | Y47 | Sugiyama | SYNCRIP HNRPQ NSAP1 | FQTLLDAGLPQKVAEKLDEIyVAGLVAHsDLDERAIEALKE |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y257 | Sugiyama | CTNND1 KIAA0384 | IEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDLHRFHP |
| O60763 | Y655 | Sugiyama | USO1 VDP | DKKEEEVKKTLEQHDNIVTHyKNMIREQDLQLEELRQQVST |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60884 | Y66 | Sugiyama | DNAJA2 CPR3 HIRIP4 | KFKEISFAyEVLSNPEKRELyDRyGEQGLREGsGGGGGMDD |
| O60884 | Y69 | Sugiyama | DNAJA2 CPR3 HIRIP4 | EISFAyEVLSNPEKRELyDRyGEQGLREGsGGGGGMDDIFS |
| O75116 | Y722 | Sugiyama | ROCK2 KIAA0619 | EQEEAEHKATKARLADKNKIyEsIEEAKSEAMKEMEKKLLE |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75369 | Y315 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | DPEGNKEEAQVTPDSDKNKTySVEyLPKVTGLHKVTVLFAG |
| O75390 | Y345 | Sugiyama | CS | DEKLRDYIWNtLNSGRVVPGyGHAVLRKTDPRYTCQREFAL |
| O75643 | Y361 | Sugiyama | SNRNP200 ASCC3L1 BRR2 HELIC2 KIAA0788 | AEKERIMGKMEADPELSKFLyQLHETEKEDLIREERSRRER |
| O75688 | Y367 | Sugiyama | PPM1B PP2CB | IPNLPPGGGLAGKRNVIEAVySRLNPHREsDGAsDEAEEsG |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O75962 | Y621 | Sugiyama | TRIO | HRARALQKRHEDFEEVAQNTyTNADKLLEAAEQLAQTGECD |
| O75976 | Y1376 | Sugiyama | CPD | KKsLLsHEFQDEtDtEEEtLyssKH________________ |
| O94776 | T439 | Sugiyama | MTA2 MTA1L1 PID | EPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQtT |
| O94776 | Y437 | Sugiyama | MTA2 MTA1L1 PID | tTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQ |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y124 | Sugiyama | ZRANB2 ZIS ZNF265 | GGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVGPAsI |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95340 | Y182 | Sugiyama | PAPSS2 ATPSK2 | GLYKRARAGEIKGFTGIDsDyEKPEtPERVLKTNLSTVSDC |
| O95757 | Y30 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | FLNCYIAVARsGGIETIANEySDRCtPACIsLGSRTRAIGN |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O96019 | Y68 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DDGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPL |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y172 | Sugiyama | LDHA PIG19 | GFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHGWVLGE |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00390 | Y371 | Sugiyama | GSR GLUR GRD1 | TDDKGHIIVDEFQNtNVKGIyAVGDVCGKALLtPVAIAAGR |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P00966 | Y207 | Sugiyama | ASS1 ASS | HIsyEAGILENPKNQAPPGLytKtQDPAKAPNtPDILEIEF |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P02786 | Y168 | Sugiyama | TFRC | NENsyVPREAGsQKDENLALyVENQFREFKLSKVWRDQHFV |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04406 | Y94 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ItIFQERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQG |
| P04818 | Y135 | Sugiyama | TYMS TS OK/SW-cl.29 | RDFLDsLGFsTREEGDLGPVyGFQWRHFGAEyRDMEsDysG |
| P05187 | Y182 | Sugiyama | ALPP PLAP | GKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQ |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05787 | Y282 | Sugiyama | KRT8 CYK8 | EVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRR |
| P06493 | Y15 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P06493 | Y270 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ASHVKNLDENGLDLLSKMLIyDPAKRISGKMALNHPyFNDL |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y131 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ILGVsLAVCKAGAVEKGVPLyRHIADLAGNsEVILPVPAFN |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07195 | S85 | Sugiyama | LDHB | DLQHGsLFLQtPKIVADKDysVtANSKIVVVtAGVRQQEGE |
| P07195 | Y173 | Sugiyama | LDHB | GLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHGWILGE |
| P07195 | Y240 | Sugiyama | LDHB | GTDNDSENWKEVHKMVVEsAyEVIKLKGYTNWAIGLSVADL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y327 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LKKEECPAVRLITLEEEMTKyKPEsEELtAERItEFCHRFL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07355 | Y30 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKG |
| P07355 | Y75 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | tIVNILTNRSNAQRQDIAFAyQRRTKKELASALKsALsGHL |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | Y106 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAES |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07741 | Y60 | Sugiyama | APRT | RAAIGLLARHLKATHGGRIDyIAGLDsRGFLFGPSLAQELG |
| P07814 | Y290 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | SDHFETIMKYAEKLIQEGKAyVDDtPAEQMKAEREQRIDSK |
| P07814 | Y701 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | DQPyEPVsPysCKEAPCVLIyIPDGHtKEMPTSGSKEKTKV |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07814 | Y872 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EAVECLLSLKAQYKEKTGKEyIPGQPPLsQssDssPtRNsE |
| P07858 | T218 | Sugiyama | CTSB CPSB | CTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSEKD |
| P07858 | Y219 | Sugiyama | CTSB CPSB | TGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSEKDI |
| P07858 | Y244 | Sugiyama | CTSB CPSB | HYGYNSYSVSNSEKDIMAEIyKNGPVEGAFSVYSDFLLYKS |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y466 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKE |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y520 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DQVANsAFVERLRKHGLEVIyMIEPIDEyCVQQLKEFEGKt |
| P07900 | Y528 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VERLRKHGLEVIyMIEPIDEyCVQQLKEFEGKtLVsVTKEG |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07900 | Y627 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIEtLR |
| P07942 | Y1002 | Sugiyama | LAMB1 | IDTTDPEACDKETGRCLKCLyHtEGEHCQFCRFGyyGDALQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S482 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sGDEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVER |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08670 | Y291 | Sugiyama | VIM | DVRQQyEsVAAKNLQEAEEWyKSKFADLsEAANRNNDALRQ |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | S135 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | AsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRMLVV |
| P08758 | Y91 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | SELTGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLt |
| P08758 | Y94 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | TGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLtEII |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09651 | Y253 | Sugiyama | HNRNPA1 HNRPA1 | GGGGYGGSGDGyNGFGNDGGyGGGGPGYSGGSRGYGSGGQG |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09923 | Y179 | Sugiyama | ALPI | GKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQ |
| P09923 | Y188 | Sugiyama | ALPI | TRVQHAsPAGtyAHtVNRNWysDADMPASARQEGCQDIATQ |
| P09960 | Y131 | Sugiyama | LTA4H LTA4 | PKSSALQWLTPEQTSGKEHPyLFSQCQAIHCRAILPCQDTP |
| P09960 | Y233 | Sugiyama | LTA4H LTA4 | RQIGPRTLVWSEKEQVEKSAyEFsETEsMLKIAEDLGGPYV |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG38 | Y791 | Sugiyama | POTEI | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y754 | Sugiyama | POTEJ | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| P0DPH7 | T225 | Sugiyama | TUBA3C TUBA2 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| P0DPH7 | T94 | Sugiyama | TUBA3C TUBA2 | VVDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| P0DPH7 | Y103 | Sugiyama | TUBA3C TUBA2 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIVDLVLDRIR |
| P10109 | Y142 | Sugiyama | FDX1 ADX | HIYEKLDAITDEENDMLDLAyGLTDRsRLGCQICLTKsMDN |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y358 | Sugiyama | LAMC1 LAMB2 | ECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQDNTDGAH |
| P11047 | Y854 | Sugiyama | LAMC1 LAMB2 | IDPNAVGNCNRLTGECLKCIyNtAGFyCDRCKDGFFGNPLA |
| P11047 | Y860 | Sugiyama | LAMC1 LAMB2 | GNCNRLTGECLKCIyNtAGFyCDRCKDGFFGNPLAPNPADK |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T427 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGER |
| P11142 | Y134 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FYPEEVSSMVLTKMKEIAEAyLGKtVTNAVVtVPAyFNDsQ |
| P11142 | Y149 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIAEAyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNV |
| P11142 | Y183 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | tIAGLNVLRIINEPtAAAIAyGLDKKVGAERNVLIFDLGGG |
| P11142 | Y443 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KQtQtFttysDNQPGVLIQVyEGERAMTKDNNLLGKFELTG |
| P11413 | T506 | Sugiyama | G6PD | sRGPTEADELMKRVGFQyEGtyKWVNPHKL___________ |
| P11413 | Y503 | Sugiyama | G6PD | IYGsRGPTEADELMKRVGFQyEGtyKWVNPHKL________ |
| P11413 | Y507 | Sugiyama | G6PD | RGPTEADELMKRVGFQyEGtyKWVNPHKL____________ |
| P11498 | Y84 | Sugiyama | PC | VAIYSEQDTGQMHRQKADEAyLIGRGLAPVQAYLHIPDIIK |
| P11586 | Y258 | Sugiyama | MTHFD1 MTHFC MTHFD | INYVPDDKKPNGRKVVGDVAyDEAKERASFITPVPGGVGPM |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P11940 | Y382 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | PLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINPYQP |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12814 | T706 | Sugiyama | ACTN1 | DQLEGDHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIAR |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y708 | Sugiyama | ACTN1 | LEGDHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIARTI |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P12956 | Y103 | Sugiyama | XRCC6 G22P1 | LAVVFYGTEKDKNSVNFKNIyVLQELDNPGAKRILELDQFK |
| P13639 | T582 | Sugiyama | EEF2 EF2 | EEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRL |
| P13639 | Y367 | Sugiyama | EEF2 EF2 | GDALLQMITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKs |
| P13639 | Y373 | Sugiyama | EEF2 EF2 | MITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKsCDPKGP |
| P13639 | Y411 | Sugiyama | EEF2 EF2 | KGPLMMYISKMVPTSDKGRFyAFGRVFsGLVsTGLKVRIMG |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y273 | Sugiyama | PDIA4 ERP70 ERP72 | PTLKIFRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTL |
| P13667 | Y278 | Sugiyama | PDIA4 ERP70 ERP72 | FRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTLKQVQE |
| P13667 | Y392 | Sugiyama | PDIA4 ERP70 ERP72 | HMMDVQGstQDsAIKDFVLKyALPLVGHRKVSNDAKRYTRR |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13796 | Y462 | Sugiyama | LCP1 PLS2 | VNKPPYPKLGGNMKKLENCNyAVELGKNQAKFsLVGIGGQD |
| P13797 | Y465 | Sugiyama | PLS3 | VNKPPYPKLGANMKKLENCNyAVELGKHPAKFSLVGIGGQD |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13861 | Y177 | Sugiyama | PRKAR2A PKR2 PRKAR2 | ERIVKADEHVIDQGDDGDNFyVIERGTyDILVTKDNQTRSV |
| P13929 | Y131 | Sugiyama | ENO3 | ILGVSLAVCKAGAAEKGVPLyRHIADLAGNPDLILPVPAFN |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14324 | Y349 | Sugiyama | FDPS FPS KIAA1293 | QDNKCSWLVVQCLQRATPEQyQILKENYGQKEAEKVARVKA |
| P14618 | Y105 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIRtGLIK |
| P14618 | Y148 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | GtAEVELKKGATLKITLDNAyMEKCDENILWLDYKNICKVV |
| P14625 | S650 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KIEKAVVSQRLTESPCALVAsQyGWsGNMERIMKAQAYQtG |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14625 | Y652 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | EKAVVSQRLTESPCALVAsQyGWsGNMERIMKAQAYQtGKD |
| P14625 | Y678 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDML |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P14866 | Y257 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | EFDSVQSAQRAKASLNGADIysGCCTLKIEYAKPTRLNVFK |
| P14868 | Y389 | Sugiyama | DARS1 DARS PIG40 | stPNEKLLGHLVKEKyDTDFyILDKYPLAVRPFYTMPDPRN |
| P14927 | Y56 | Sugiyama | UQCRB UQBP | DTIYEDEDVKEAIRRLPENLyNDRMFRIKRALDLNLKHQIL |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15328 | Y82 | Sugiyama | FOLR1 FOLR | KNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHFIQ |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y185 | Sugiyama | HSPA6 HSP70B' | AIAGLNVLRIINEPTAAAIAyGLDRRGAGERNVLIFDLGGG |
| P17812 | Y468 | Sugiyama | CTPS1 CTPS | MRLGKRRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVW |
| P17980 | Y168 | Sugiyama | PSMC3 TBP1 | GDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtEQysDI |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18124 | Y82 | Sugiyama | RPL7 | RQMYRTEIRMARMARKAGNFyVPAEPKLAFVIRIRGINGVS |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | Y4 | Sugiyama | RPL17 | _________________MVRysLDPENPtKsCKSRGSNLRV |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y133 | Sugiyama | PGAM1 PGAMA CDABP0006 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsC |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P18754 | Y89 | Sugiyama | RCC1 CHC1 | VVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSE |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19367 | Y732 | Sugiyama | HK1 | FGDNGCLDDIRTHYDRLVDEysLNAGKQRYEKMISGMYLGE |
| P19838 | Y240 | Sugiyama | NFKB1 | LPDSTGSFTRRLEPVVSDAIyDSKAPNASNLKIVRMDRTAG |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P20618 | Y216 | Sugiyama | PSMB1 PSC5 | LDRAMRLVKDVFISAAERDVytGDALRICIVTKEGIREETV |
| P20810 | Y339 | Sugiyama | CAST | KAKEEKLEKCGEDDEtIPsEyRLKPATDKDGKPLLPEPEEK |
| P21127 | Y449 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | LQGCRsVEEFQCLNRIEEGtyGVVYRAKDKKTDEIVALKRL |
| P21333 | Y1519 | Sugiyama | FLNA FLN FLN1 | VVDNADGTQTVNyVPSREGPysIsVLyGDEEVPRsPFKVKV |
| P21333 | Y1525 | Sugiyama | FLNA FLN FLN1 | GTQTVNyVPSREGPysIsVLyGDEEVPRsPFKVKVLPTHDA |
| P21333 | Y731 | Sugiyama | FLNA FLN FLN1 | VQDNEGCPVEALVKDNGNGtysCSyVPRKPVKHTAMVSWGG |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22087 | Y118 | Sugiyama | FBL FIB1 FLRN | ICRGKEDALVTKNLVPGEsVyGEKRVsIsEGDDKIEyRAWN |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22234 | Y316 | Sugiyama | PAICS ADE2 AIRC PAIS | ELRVTSAHKGPDETLRIKAEyEGDGIPTVFVAVAGRSNGLG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22314 | Y560 | Sugiyama | UBA1 A1S9T UBE1 | NPHIRVTSHQNRVGPDtERIyDDDFFQNLDGVANALDNVDA |
| P22314 | Y60 | Sugiyama | UBA1 A1S9T UBE1 | GMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVLVSGL |
| P22314 | Y666 | Sugiyama | UBA1 A1S9T UBE1 | QWARDEFEGLFKQPAENVNQyLtDPKFVERtLRLAGtQPLE |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22570 | Y68 | Sugiyama | FDXR ADXR | PAGFYTAQHLLKHPQAHVDIyEKQPVPFGLVRFGVAPDHPE |
| P22626 | Y331 | Sugiyama | HNRNPA2B1 HNRPA2B1 | SNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRs |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23142 | Y175 | Sugiyama | FBLN1 PP213 | VGGLQETDKIIEVEEEQEDPyLNDRCRGGGPCKQQCRDTGD |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | Y691 | Sugiyama | SFPQ PSF | GAGPVGGQGPRGMGPGtPAGyGRGREEYEGPNKKPRF____ |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23284 | Y133 | Sugiyama | PPIB CYPB | tGGKsIyGERFPDENFKLKHyGPGWVsMANAGKDTNGsQFF |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P23921 | Y553 | Sugiyama | RRM1 RR1 | EtIyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNV |
| P23921 | Y556 | Sugiyama | RRM1 RR1 | yyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPT |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y219 | Sugiyama | ACAT1 ACAT MAT | NTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVt |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P24941 | Y15 | Sugiyama | CDK2 CDKN2 | ______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKI |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y45 | Sugiyama | MCM3 | DEEDQGIyQsKVRELIsDNQyRLIVNVNDLRRKNEKRANRL |
| P25205 | Y456 | Sugiyama | MCM3 | AGIHARLNARCsVLAAANPVyGRyDQyKTPMENIGLQDSLL |
| P25205 | Y708 | Sugiyama | MCM3 | KRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADs |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P25787 | Y57 | Sugiyama | PSMA2 HC3 PSC3 | GIKAANGVVLATEKKQKSILyDERSVHKVEPITKHIGLVys |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P26639 | Y540 | Sugiyama | TARS1 TARS | ENsLNEFGEKWELNsGDGAFyGPKIDIQIKDAIGRYHQCAT |
| P26639 | Y575 | Sugiyama | TARS1 TARS | YHQCATIQLDFQLPIRFNLtyVsHDGDDKKRPVIVHRAILG |
| P26640 | Y601 | Sugiyama | VARS1 G7A VARS VARS2 | VDMDFGTGAVKITPAHDQNDyEVGQRHGLEAIsIMDsRGAL |
| P26641 | Y297 | Sugiyama | EEF1G EF1G PRO1608 | KDPFAHLPKstFVLDEFKRKysNEDtLsVALPyFWEHFDKD |
| P26641 | Y309 | Sugiyama | EEF1G EF1G PRO1608 | VLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLWySEYRFP |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y144 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | DKEGysGVGLLsRQCPLKVsyGIGDEEHDQEGRVIVAEFDS |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27797 | Y57 | Sugiyama | CALR CRTC | WIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDARFyAL |
| P27797 | Y75 | Sugiyama | CALR CRTC | KFyGDEEKDKGLQTSQDARFyALsAsFEPFSNKGQTLVVQF |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P28066 | Y8 | Sugiyama | PSMA5 | _____________MFLTRsEyDRGVNtFsPEGRLFQVEyAI |
| P28074 | Y172 | Sugiyama | PSMB5 LMPX MB1 X | MGLSMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSV |
| P29144 | Y1042 | Sugiyama | TPP2 | TEALRDLKIQWMTKLDSsDIyNELKEtyPNyLPLyVARLHQ |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | S276 | Sugiyama | TKT | sWHGKPLPKNMAEQIIQEIysQIQsKKKILAtPPQEDAPsV |
| P29401 | Y202 | Sugiyama | TKT | LDINRLGQsDPAPLQHQMDIyQKRCEAFGWHAIIVDGHSVE |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30041 | Y89 | Sugiyama | PRDX6 AOP2 KIAA0106 | IALSIDSVEDHLAWSKDINAyNCEEPtEKLPFPIIDDRNRE |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30043 | Y194 | Sugiyama | BLVRB FLR SCAN | RVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ________ |
| P30043 | Y200 | Sugiyama | BLVRB FLR SCAN | DLGHFMLRCLttDEyDGHstyPsHQyQ______________ |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y169 | Sugiyama | PEBP1 PBP PEBP | FKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK__ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30740 | Y112 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | LYGEKTYNFLPEFLVSTQKtyGADLAsVDFQHASEDARKTI |
| P31153 | Y188 | Sugiyama | MAT2A AMS2 MATA2 | RRNGTLPWLRPDSKTQVTVQyMQDRGAVLPIRVHTIVISVQ |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31327 | Y162 | Sugiyama | CPS1 | HWLATKsLGQWLQEEKVPAIyGVDtRMLTKIIRDKGTMLGK |
| P31749 | Y315 | SIGNOR|EPSD|PSP | AKT1 PKB RAC | LCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGRAVDWWGL |
| P31749 | Y326 | SIGNOR|EPSD|PSP | AKT1 PKB RAC | MKtFCGtPEyLAPEVLEDNDyGRAVDWWGLGVVMYEMMCGR |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31943 | Y276 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | GSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGL |
| P31946 | S212 | Sugiyama | YWHAB | SLAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtS |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | S149 | Sugiyama | SFN HME1 | RyLAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIR |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y213 | Sugiyama | SFN HME1 | LAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNLtLWTAD |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P31949 | Y32 | Sugiyama | S100A11 MLN70 S100C | RCIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTK |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32322 | T137 | Sugiyama | PYCR1 | VIRCMTNTPVVVREGATVyAtGTHAQVEDGRLMEQLLSSVG |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32929 | Y114 | Sugiyama | CTH | TVTITHLLKAGDQIICMDDVyGGTNRYFRQVASEFGLKISF |
| P32929 | Y60 | Sugiyama | CTH | PISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDG |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P33992 | Y403 | Sugiyama | MCM5 CDC46 | PGTAKSQLLKFVEKCsPIGVytsGKGSSAAGLtAsVMRDPs |
| P33993 | Y102 | Sugiyama | MCM7 CDC47 MCM2 | QELLPQYKEREVVNKDVLDVyIEHRLMMEQRSRDPGMVRsP |
| P33993 | Y333 | Sugiyama | MCM7 CDC47 MCM2 | EsGAGELtREELRQIAEEDFyEKLAASIAPEIYGHEDVKKA |
| P34897 | Y105 | Sugiyama | SHMT2 | LEALGsCLNNKYSEGYPGKRyyGGAEVVDEIELLCQRRALE |
| P34897 | Y106 | Sugiyama | SHMT2 | EALGsCLNNKYSEGYPGKRyyGGAEVVDEIELLCQRRALEA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | Y185 | Sugiyama | HSPA1L | VIAGLNVLRIINEPtAAAIAyGLDKGGQGERHVLIFDLGGG |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y336 | Sugiyama | HSPA4 APG2 HSPH2 | RVEPPLRSVLEQTKLKKEDIyAVEIVGGATRIPAVKEKISK |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P34932 | Y660 | Sugiyama | HSPA4 APG2 HSPH2 | VSEDDRNsFtLKLEDTENWLyEDGEDQPKQVYVDKLAELKN |
| P35080 | Y99 | Sugiyama | PFN2 | yVDGDCtMDIRTKsQGGEPTyNVAVGRAGRVLVFVMGKEGV |
| P35222 | Y142 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | VQRLAEPSQMLKHAVVNLINyQDDAELATRAIPELTKLLND |
| P35222 | Y331 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | sKLIILASGGPQALVNIMRTytyEKLLWTTSRVLKVLSVCS |
| P35222 | Y333 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | LIILASGGPQALVNIMRTytyEKLLWTTSRVLKVLSVCSsN |
| P35222 | Y64 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | PsLsGKGNPEEEDVDTsQVLyEWEQGFSQsFTQEQVADIDG |
| P35270 | Y259 | Sugiyama | SPR | QKLLSLLEKDEFKSGAHVDFyDK__________________ |
| P35579 | Y297 | Sugiyama | MYH9 | FYYLLSGAGEHLKTDLLLEPyNKyRFLsNGHVtIPGQQDKD |
| P35606 | Y193 | Sugiyama | COPB2 | GsssPNFTLEGHEKGVNCIDyysGGDKPyLIsGADDRLVKI |
| P35606 | Y194 | Sugiyama | COPB2 | sssPNFTLEGHEKGVNCIDyysGGDKPyLIsGADDRLVKIW |
| P35609 | T713 | Sugiyama | ACTN2 | DKLEGDHQLIQEALVFDNKHtNytMEHIRVGWELLLTTIAR |
| P35609 | Y715 | Sugiyama | ACTN2 | LEGDHQLIQEALVFDNKHtNytMEHIRVGWELLLTTIARTI |
| P35613 | Y299 | Sugiyama | BSG UNQ6505/PRO21383 | sQGRSELHIENLNMEADPGQyRCNGTSSKGSDQAIITLRVR |
| P35637 | Y468 | Sugiyama | FUS TLS | KAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRGGYRGRG |
| P35813 | Y362 | Sugiyama | PPM1A PPPM1A | IPSLPPGGELASKRNVIEAVyNRLNPYKNDDTDsTsTDDMW |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37837 | Y206 | Sugiyama | TALDO1 TAL TALDO TALDOR | ISPFVGRILDWHVANTDKKSyEPLEDPGVKSVTKIYNYYKK |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P38646 | Y230 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QIsGLNVLRVINEPTAAALAyGLDKSEDKVIAVYDLGGGTF |
| P38919 | Y54 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VDVTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIK |
| P38919 | Y56 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIKGR |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40227 | Y109 | Sugiyama | CCT6A CCT6 CCTZ | GDGTTsNVLIIGELLKQADLyISEGLHPRIITEGFEAAKEK |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40337 | Y185 | Sugiyama | VHL | VVRsLVKPENyRRLDIVRsLyEDLEDHPNVQKDLERLtQER |
| P40763 | Y705 | GPS6 | STAT3 APRF | KyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNtIDLP |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P41091 | Y102 | Sugiyama | EIF2S3 EIF2G | GYANAKIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKG |
| P41212 | Y447 | Sugiyama | ETV6 TEL TEL1 | MSGRTDRLEHLEsQELDEQIyQEDEC_______________ |
| P41219 | Y287 | Sugiyama | PRPH NEF4 PRPH1 | DIRAQYESIAAKNLQEAEEWyKSKYADLSDAANRNHEALRQ |
| P41227 | Y145 | Sugiyama | NAA10 ARD1 ARD1A TE2 | TLNFQISEVEPKyyADGEDAyAMKRDLtQMADELRRHLELK |
| P41236 | Y148 | Sugiyama | PPP1R2 IPP2 | DLsPEEREKKRQFEMKRKLHyNEGLNIKLARQLISKDLHDD |
| P41252 | Y680 | Sugiyama | IARS1 IARS | YRFLIQNVLRLQKEEEIEFLyNENTVRESPNITDRWILSFM |
| P43243 | Y158 | Sugiyama | MATR3 KIAA0723 | LPQILLQLKRRRtEEGPtLsyGRDGRsAtREPPyRVPRDDW |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y219 | Sugiyama | MATR3 KIAA0723 | VLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDsFFGEt |
| P43268 | Y392 | PSP | ETV4 E1AF PEA3 | IEPEEVARLWGIQKNRPAMNyDKLSRSLRYYYEKGIMQKVA |
| P43490 | Y188 | Sugiyama | NAMPT PBEF PBEF1 | QKKILAKyLLEtsGNLDGLEyKLHDFGyRGVSSQETAGIGA |
| P43490 | Y471 | Sugiyama | NAMPT PBEF PBEF1 | EEYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH |
| P46776 | Y48 | Sugiyama | RPL27A | HPGGRGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQs |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46777 | Y240 | Sugiyama | RPL5 MSTP030 | KKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPVyEKKPKKE |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46940 | Y1095 | Sugiyama | IQGAP1 KIAA0051 | VVKEIMDDKSLNIKTDPVDIyKsWVNQMESQTGEASKLPyD |
| P46940 | Y140 | Sugiyama | IQGAP1 KIAA0051 | LNAMDEIGLPKIFYPETTDIyDRKNMPRCIYCIHALSLYLF |
| P47712 | Y456 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | DsDDEsHEPKGtENEDAGsDyQsDNQASWIHRMIMALVSDS |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49023 | Y118 | GPS6|ELM|EPSD|PSP | PXN | sNPQDsVGsPCsRVGEEEHVysFPNKQKsAEPsPtVMstsL |
| P49023 | Y31 | GPS6|ELM|EPSD|PSP | PXN | LESTTSHISKRPVFLSEETPySYPTGNHTyQEIAVPPPVPP |
| P49023 | Y88 | Sugiyama | PXN | QWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsVGsPC |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y277 | Sugiyama | FASN FAS | KEQGVtFPsGDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGT |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49368 | Y247 | Sugiyama | CCT3 CCTG TRIC5 | PRMRRYIKNPRIVLLDssLEyKKGEsQtDIEITREEDFTRI |
| P49419 | T68 | Sugiyama | ALDH7A1 ATQ1 | REENEGVyNGSWGGRGEVIttyCPANNEPIARVRQAsVADy |
| P49419 | Y55 | Sugiyama | ALDH7A1 ATQ1 | NQPQYAWLKELGLREENEGVyNGSWGGRGEVIttyCPANNE |
| P49419 | Y69 | Sugiyama | ALDH7A1 ATQ1 | EENEGVyNGSWGGRGEVIttyCPANNEPIARVRQAsVADyE |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P49588 | Y667 | Sugiyama | AARS1 AARS | QQIKKAEEIANEMIEAAKAVyTQDCPLAAAKAIQGLRAVFD |
| P49736 | Y137 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | MRQRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERA |
| P49792 | Y3139 | Sugiyama | RANBP2 NUP358 | DFVCQGGDITKHDGTGGQsIyGDKFEDENFDVKHTGPGLLS |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50395 | Y286 | Sugiyama | GDI2 RABGDIB | IGVKsEGEIARCKQLICDPSyVKDRVEKVGQVIRVICILSH |
| P50395 | Y404 | Sugiyama | GDI2 RABGDIB | SDLLVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRM |
| P50454 | Y135 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LRSLSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYN |
| P50454 | Y246 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | VTRSYTVGVMMMHRTGLyNyyDDEKEKLQIVEMPLAHKLsS |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50990 | Y426 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | KRLVPGGGAtEIELAKQItsyGETCPGLEQyAIKKFAEAFE |
| P50990 | Y436 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EIELAKQItsyGETCPGLEQyAIKKFAEAFEAIPRALAENS |
| P50995 | Y365 | Sugiyama | ANXA11 ANX11 | NRDESTNVDMSLAQRDAQELyAAGENRLGTDESKFNAVLCS |
| P51116 | Y443 | Sugiyama | FXR2 FMR1L2 | RTYGGSYGGRGRGRRTGGPAyGPssDVstAsEtEsEKREEP |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51692 | Y699 | SIGNOR|EPSD|PSP | STAT5B | ySKyytPVPCESATAKAVDGyVKPQIKQVVPEFVNASADAG |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P51991 | Y360 | Sugiyama | HNRNPA3 HNRPA3 | QSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF__ |
| P52209 | Y137 | Sugiyama | PGD PGDH | KAKGILFVGsGVsGGEEGARyGPSLMPGGNKEAWPHIKTIF |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52789 | Y27 | Sugiyama | HK2 | LAYFFTELNHDQVQKVDQyLyHMRLSDETLLEISKRFRKEM |
| P53041 | Y422 | Sugiyama | PPP5C PPP5 | VsCQFGPDVTKAFLEENNLDyIIRSHEVKAEGYEVAHGGRC |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P53396 | Y252 | Sugiyama | ACLY | KWGDIEFPPPFGREAyPEEAyIADLDAKSGASLKLTLLNPK |
| P53396 | Y652 | Sugiyama | ACLY | GCFKIGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNN |
| P53396 | Y659 | Sugiyama | ACLY | TGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISRTTD |
| P53621 | Y249 | Sugiyama | COPA | VKIWRMNESKAWEVDTCRGHyNNVSCAVFHPRQELILsNsE |
| P53621 | Y391 | Sugiyama | COPA | NPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEGK |
| P53621 | Y394 | Sugiyama | COPA | ENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEGKRSS |
| P53675 | Y921 | Sugiyama | CLTCL1 CLH22 CLTCL CLTD | DSSVVGRYCEKRDPHLACVAyERGQCDLELIKVCNENSLFK |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | Y184 | Sugiyama | HSPA2 | tITGLNVLRIINEPtAAAIAyGLDKKGCAGGEKNVLIFDLG |
| P55010 | Y14 | Sugiyama | EIF5 | _______MSVNVNRsVsDQFyRyKMPRLIAKVEGKGNGIKT |
| P55060 | Y278 | Sugiyama | CSE1L CAS XPO2 | EEEAGLLELLKSQICDNAALyAQKyDEEFQRYLPRFVTAIW |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P56945 | Y165 | SIGNOR|EPSD|PSP | BCAR1 CAS CASS1 CRKAS | TSTFSKQTPHHPFPSPATDLyQVPPGPGGPAQDIyQVPPSA |
| P56945 | Y664 | SIGNOR|EPSD|PSP | BCAR1 CAS CASS1 CRKAS | tsQDsPDGQyENSEGGWMEDyDyVHLQGKEEFEKTQKELLE |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60174 | Y68 | Sugiyama | TPI1 TPI | yIDFARQKLDPKIAVAAQNCyKVTNGAFtGEIsPGMIKDCG |
| P60510 | Y124 | Sugiyama | PPP4C PPP4 PPX | YPDRITLIRGNHESRQITQVyGFyDECLRKYGSVTVWRYCT |
| P60510 | Y127 | Sugiyama | PPP4C PPP4 PPX | RITLIRGNHESRQITQVyGFyDECLRKYGSVTVWRYCTEIF |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60709 | Y91 | Sugiyama | ACTB | IEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAPLN |
| P60842 | T393 | Sugiyama | EIF4A1 DDX2A EIF4A | INMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI_______ |
| P60842 | Y391 | Sugiyama | EIF4A1 DDX2A EIF4A | VAINMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI_____ |
| P60842 | Y48 | Sugiyama | EIF4A1 DDX2A EIF4A | NEIVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIK |
| P60842 | Y50 | Sugiyama | EIF4A1 DDX2A EIF4A | IVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIKGy |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61163 | Y241 | Sugiyama | ACTR1A CTRN1 | ACYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPEL |
| P61163 | Y242 | Sugiyama | ACTR1A CTRN1 | CYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPELL |
| P61224 | S39 | Sugiyama | RAP1B OK/SW-cl.11 | LTVQFVQGIFVEKYDPTIEDsyRKQVEVDAQQCMLEILDTA |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61313 | Y62 | Sugiyama | RPL15 EC45 TCBAP0781 | PTRPDKARRLGYKAKQGyVIyRIRVRRGGRKRPVPKGAtyG |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P61353 | Y75 | Sugiyama | RPL27 | AAMGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtV |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61758 | Y112 | Sugiyama | VBP1 PFDN3 | QKKKESTNSMETRFLLADNLyCKASVPPTDKVCLWLGANVM |
| P61758 | Y180 | Sugiyama | VBP1 PFDN3 | EDLDFLRDQFTtTEVNMARVyNWDVKRRNKDDSTKNKA___ |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62140 | Y304 | Sugiyama | PPP1CB | VDETLMCSFQILKPSEKKAKyQyGGLNsGRPVtPPRTANPP |
| P62140 | Y306 | Sugiyama | PPP1CB | ETLMCSFQILKPSEKKAKyQyGGLNsGRPVtPPRTANPPKK |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y20 | Sugiyama | YWHAE | _MDDREDLVyQAKLAEQAERyDEMVESMKKVAGMDVELTVE |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S69 | Sugiyama | RPS14 PRO2640 | GKETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELG |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y34 | Sugiyama | RPS29 | FGQGSRSCRVCSNRHGLIRKyGLNMCRQCFRQYAKDIGFIK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62333 | Y328 | Sugiyama | PSMC6 SUG2 | ARLDILKIHAGPITKHGEIDyEAIVKLSDGFNGADLRNVCT |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62714 | Y127 | Sugiyama | PPP2CB | YPERITILRGNHESRQITQVyGFyDECLRKYGNANVWKYFT |
| P62714 | Y130 | Sugiyama | PPP2CB | RITILRGNHESRQITQVyGFyDECLRKYGNANVWKYFTDLF |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y117 | Sugiyama | RPL23A | VFIVDVKANKHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAY |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62829 | Y38 | Sugiyama | RPL23 | LGLPVGAVINCADNTGAKNLyIIsVKGIKGRLNRLPAAGVG |
| P62834 | S39 | Sugiyama | RAP1A KREV1 | LTVQFVQGIFVEKYDPTIEDsyRKQVEVDCQQCMLEILDTA |
| P62847 | Y76 | Sugiyama | RPS24 | FVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGL |
| P62847 | Y81 | Sugiyama | RPS24 | RTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYEKKK |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63010 | Y874 | Sugiyama | AP2B1 ADTB2 CLAPB1 | IKECHLNADTVSSKLQNNNVyTIAKRNVEGQDMLyQSLKLT |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63151 | Y74 | Sugiyama | PPP2R2A | IFQQEQENKIQSHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63261 | Y91 | Sugiyama | ACTG1 ACTG | IEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAPLN |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | Y127 | Sugiyama | PPP2CA | YRERITILRGNHESRQITQVyGFyDECLRKYGNANVWKYFT |
| P67775 | Y130 | Sugiyama | PPP2CA | RITILRGNHESRQITQVyGFyDECLRKYGNANVWKYFTDLF |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y93 | Sugiyama | ACTC1 ACTC | IEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAPLN |
| P68104 | Y254 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y93 | Sugiyama | ACTA1 ACTA | IEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAPLN |
| P68363 | T225 | Sugiyama | TUBA1B | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P68363 | T94 | Sugiyama | TUBA1B | VIDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| P68363 | Y103 | Sugiyama | TUBA1B | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| P68366 | T225 | Sugiyama | TUBA4A TUBA1 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P68366 | T94 | Sugiyama | TUBA4A TUBA1 | VIDEIRNGPYRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| P68366 | Y103 | Sugiyama | TUBA4A TUBA1 | YRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDPVLDRIR |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00005 | Y70 | Sugiyama | PPP2R2B | IFQREQESKNQVHRRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q00526 | Y15 | Sugiyama | CDK3 CDKN3 | ______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKKI |
| Q00610 | Y1218 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | IQQVGDRCyDEKMyDAAKLLyNNVsNFGRLAstLVHLGEyQ |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00610 | Y899 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACV |
| Q00610 | Y921 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | DsRVVGKYCEKRDPHLACVAyERGQCDLELINVCNENSLFK |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y135 | Sugiyama | SET | EALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKE |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01518 | S25 | Sugiyama | CAP1 CAP | QNLVERLERAVGRLEAVSHtsDMHRGyADsPsKAGAAPyVQ |
| Q01518 | Y164 | Sugiyama | CAP1 CAP | VAMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVK |
| Q01518 | Y31 | Sugiyama | CAP1 CAP | LERAVGRLEAVSHtsDMHRGyADsPsKAGAAPyVQAFDSLL |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04637 | Y594 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | WDSKEDKIHNAENIQPGEQKyEyKsDQWKPLNLEEKKRYDR |
| Q04637 | Y596 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | SKEDKIHNAENIQPGEQKyEyKsDQWKPLNLEEKKRYDREF |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05519 | Y425 | Sugiyama | SRSF11 SFRS11 | EKDRERKSEsDKDVKQVtRDyDEEEQGYDsEKEKKEEKKPI |
| Q05639 | Y254 | Sugiyama | EEF1A2 EEF1AL STN | TILPPTRPTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRP |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | Y1195 | Sugiyama | TJP1 ZO1 | AQPHPsAGPKPAEsKQyFEQysRsyEQVPPQGFTSRAGHFE |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07666 | Y435 | GPS6|SIGNOR|iPTMNet|EPSD | KHDRBS1 SAM68 | DWNGTRPSLKAPPARPVKGAyREHPyGRy____________ |
| Q07666 | Y440 | GPS6|SIGNOR|iPTMNet|EPSD | KHDRBS1 SAM68 | RPSLKAPPARPVKGAyREHPyGRy_________________ |
| Q07666 | Y443 | GPS6|SIGNOR|iPTMNet|EPSD | KHDRBS1 SAM68 | LKAPPARPVKGAyREHPyGRy____________________ |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y370 | Sugiyama | DHX9 DDX9 LKP NDH2 | GPLAFATPEQISMDLKNELMyQLEQDHDLQAILQERELLPV |
| Q08211 | Y616 | Sugiyama | DHX9 DDX9 LKP NDH2 | KDDDGGEDDDANCNLICGDEyGPETRLsMsQLNEKETPFEL |
| Q08752 | Y110 | Sugiyama | PPID CYP40 CYPD | QNGTGGESIyGEKFEDENFHyKHDREGLLsMANAGRNTNGS |
| Q09028 | Y154 | Sugiyama | RBBP4 RBAP48 | PQNPCIIATKtPssDVLVFDyTKHPsKPDPsGECNPDLRLR |
| Q10713 | Y293 | Sugiyama | PMPCA INPP5E KIAA0123 MPPA | GVQPAWGSAEAVDIDRSVAQytGGIAKLERDMSNVSLGPTP |
| Q12929 | Y498 | SIGNOR | EPS8 | EHssVsEyHPADGyAFssNIytRGsHLDQGEAAVAFKPtsN |
| Q12929 | Y525 | SIGNOR | EPS8 | DQGEAAVAFKPtsNRHIDRNyEPLKTQPKKyAKSKyDFVAR |
| Q12929 | Y535 | SIGNOR | EPS8 | PtsNRHIDRNyEPLKTQPKKyAKSKyDFVARNNsELSVLKD |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q12996 | Y708 | Sugiyama | CSTF3 | NEDsDEDEEKGAVVPPVHDIyRARQQKRIR___________ |
| Q13017 | Y1109 | SIGNOR|EPSD|PSP | ARHGAP5 RHOGAP5 | DNyAEPIDTIFKQKGYsDEIyVVPDDsQNRIKIRNsFVNNt |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13155 | Y35 | Sugiyama | AIMP2 JTV1 PRO0992 | PLRVELPTCMYRLPNVHGRSyGPAPGAGHVQEEsNLsLQAL |
| Q13162 | Y54 | Sugiyama | PRDX4 | AVQGWETEERPRTREEECHFyAGGQVyPGEAsRVsVADHsL |
| Q13200 | Y110 | Sugiyama | PSMD2 TRAP2 | TSVPKPLKFLRPHyGKLKEIyENMAPGENKRFAADIISVLA |
| Q13200 | Y434 | Sugiyama | PSMD2 TRAP2 | LGMILLWDVDGGLTQIDKyLySsEDyIKSGALLACGIVNSG |
| Q13228 | Y28 | Sugiyama | SELENBP1 SBP | CGPGySTPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVD |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13242 | Y70 | Sugiyama | SRSF9 SFRS9 SRP30C | GLVPFAFVRFEDPRDAEDAIyGRNGyDYGQCRLRVEFPRTY |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13283 | Y125 | Sugiyama | G3BP1 G3BP | LRRFMQtFVLAPEGsVANKFyVHNDIFRyQDEVFGGFVtEP |
| Q13283 | Y19 | Sugiyama | G3BP1 G3BP | __MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNss |
| Q13283 | Y40 | Sugiyama | G3BP1 G3BP | ytLLNQAPDMLHRFYGKNssyVHGGLDsNGKPADAVyGQKE |
| Q13283 | Y56 | Sugiyama | G3BP1 G3BP | KNssyVHGGLDsNGKPADAVyGQKEIHRKVMsQNFtNCHTK |
| Q13371 | Y17 | Sugiyama | PDCL PHLOP1 PhLP1 | ____MTTLDDKLLGEKLQyyysssEDEDsDHEDKDRGRCAP |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13509 | Y106 | Sugiyama | TUBB3 TUBB4 | RPDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECEN |
| Q13510 | Y305 | Sugiyama | ASAH1 ASAH HSD-33 HSD33 | GNQSGEGCVITRDRKESLDVyELDAKQGRWYVVQTNYDRWK |
| Q13546 | Y384 | Sugiyama | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13546 | Y387 | Sugiyama | RIPK1 RIP RIP1 | QEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVAYNR |
| Q13547 | S88 | Sugiyama | HDAC1 RPD3L1 | HSDDyIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDGLFE |
| Q13547 | Y87 | Sugiyama | HDAC1 RPD3L1 | YHSDDyIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDGLF |
| Q13561 | Y207 | Sugiyama | DCTN2 DCTN50 | SKGGSGGKttGtPPDssLVtyELHsRPEQDKFSQAAKVAEL |
| Q13561 | Y313 | Sugiyama | DCTN2 DCTN50 | IAKHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRL |
| Q13573 | Y260 | Sugiyama | SNW1 SKIIP SKIP | KEQQEWKIPPCISNWKNAKGytIPLDKRLAADGRGLQTVHI |
| Q13573 | Y292 | Sugiyama | SNW1 SKIIP SKIP | GRGLQTVHINENFAKLAEALyIADRKAREAVEMRAQVERKM |
| Q13573 | Y459 | Sugiyama | SNW1 SKIIP SKIP | GGKDMAQsIyRPSKNLDKDMyGDDLEARIKTNRFVPDKEFS |
| Q13642 | Y149 | Sugiyama | FHL1 SLIM1 | CSNCKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAI |
| Q13882 | S117 | Sugiyama | PTK6 BRK | NATGAFLIRVSEKPSADyVLsVRDTQAVRHYKIWRRAGGRL |
| Q13882 | S147 | Sugiyama | PTK6 BRK | YKIWRRAGGRLHLNEAVSFLsLPELVNyHRAQSLSHGLRLA |
| Q13882 | S28 | Sugiyama | PTK6 BRK | HLGPKyVGLWDFKSRTDEELsFRAGDVFHVARKEEQWWWAT |
| Q13882 | Y114 | GPS6|EPSD|Sugiyama | PTK6 BRK | AEGNATGAFLIRVSEKPSADyVLsVRDTQAVRHYKIWRRAG |
| Q13882 | Y13 | GPS6|EPSD | PTK6 BRK | ________MVSRDQAHLGPKyVGLWDFKSRTDEELsFRAGD |
| Q13882 | Y154 | Sugiyama | PTK6 BRK | GGRLHLNEAVSFLsLPELVNyHRAQSLSHGLRLAAPCRKHE |
| Q13882 | Y342 | SIGNOR|ELM|EPSD|PSP|Sugiyama | PTK6 BRK | ENTLCKVGDFGLARLIKEDVyLSHDHNIPyKWTAPEALSRG |
| Q13882 | Y351 | GPS6|EPSD|Sugiyama | PTK6 BRK | FGLARLIKEDVyLSHDHNIPyKWTAPEALSRGHYSTKSDVW |
| Q13882 | Y388 | Sugiyama | PTK6 BRK | SDVWSFGILLHEMFSRGQVPyPGMSNHEAFLRVDAGyRMPC |
| Q13882 | Y404 | Sugiyama | PTK6 BRK | GQVPyPGMSNHEAFLRVDAGyRMPCPLECPPSVHKLMLTCW |
| Q13882 | Y447 | SIGNOR|ELM|EPSD|PSP|Sugiyama | PTK6 BRK | DPEQRPCFKALRERLSsFTsyENPT________________ |
| Q13882 | Y61 | GPS6|EPSD | PTK6 BRK | EEQWWWATLLDEAGGAVAQGyVPHNyLAERETVESEPWFFG |
| Q13882 | Y66 | GPS6|EPSD | PTK6 BRK | WATLLDEAGGAVAQGyVPHNyLAERETVESEPWFFGCISRS |
| Q13885 | Y106 | Sugiyama | TUBB2A TUBB2 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q14118 | T522 | Sugiyama | DAG1 | HIDRVDAWVGTYFEVKIPSDtFyDHEDTTTDKLKLTLKLRE |
| Q14118 | Y524 | Sugiyama | DAG1 | DRVDAWVGTYFEVKIPSDtFyDHEDTTTDKLKLTLKLREQQ |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14204 | Y1010 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | KMVVLSLPRIQSQRYQVGVHyELTEEEKFYRNALTRMPDGP |
| Q14204 | Y2086 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | ANKIVPFFKLCDEQLSSQSHyDFGLRALKSVLVSAGNVKRE |
| Q14240 | Y49 | Sugiyama | EIF4A2 DDX2B EIF4F | NEIVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIK |
| Q14240 | Y51 | Sugiyama | EIF4A2 DDX2B EIF4F | IVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIKGy |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y141 | Sugiyama | CTTN EMS1 | FGGKFGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGK |
| Q14247 | Y215 | Sugiyama | CTTN EMS1 | FGGKyGIDKDKVDKsAVGFEyQGKtEKHESQKDyVKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14247 | Y446 | Sugiyama | CTTN EMS1 | sFKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYAT |
| Q14257 | Y303 | Sugiyama | RCN2 ERC55 | LsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL______ |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14444 | Y99 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFMAL |
| Q14566 | Y510 | Sugiyama | MCM6 | KATLNARTsILAAANPIsGHyDRSKSLKQNINLSAPIMSRF |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14677 | Y293 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | tRHKRTANPsKtIDLGAAAHytGDKAsPDQNAstHtPQssV |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14697 | Y489 | Sugiyama | GANAB G2AN KIAA0088 | PHIKVDSGyRVHEELRNLGLyVKtRDGSDyEGWCWPGSAGY |
| Q14697 | Y563 | Sugiyama | GANAB G2AN KIAA0088 | MNEPSVFNGPEVTMLKDAQHyGGWEHRDVHNIYGLYVHMAT |
| Q14738 | Y580 | Sugiyama | PPP2R5D | KDIKKEKVLLRRKsELPQDVyTIKALEAHKRAEEFLTAsQE |
| Q15008 | Y366 | Sugiyama | PSMD6 KIAA0107 PFAAP4 | KIDKVNEIVETNRPDsKNWQyQETIKKGDLLLNRVQKLSRV |
| Q15019 | Y211 | Sugiyama | SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 | ERERLKKRILDEIEEHNIKIyHLPDAEsDEDEDFKEQtRLL |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | Y145 | Sugiyama | RCN1 RCN | KDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFK |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15293 | Y290 | Sugiyama | RCN1 RCN | RHWILPQDyDHAQAEARHLVyESDKNKDEKLTKEEILENWN |
| Q15293 | Y320 | Sugiyama | RCN1 RCN | LTKEEILENWNMFVGsQAtNyGEDLtKNHDEL_________ |
| Q15369 | T7 | Sugiyama | ELOC TCEB1 | ______________MDGEEKtyGGCEGPDAMyVKLISSDGH |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15417 | Y10 | Sugiyama | CNN3 | ___________MTHFNKGPsyGLsAEVKNKIASKYDHQAEE |
| Q15417 | Y261 | Sugiyama | CNN3 | STISLQMGTNKVAsQKGMsVyGLGRQVYDPKYCAAPTEPVI |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15631 | Y210 | Sugiyama | TSN | sLRKRYDGLKYDVKKVEEVVyDLSIRGFNKETAAACVEK__ |
| Q15637 | Y87 | Sugiyama | SF1 ZFM1 ZNF162 | tGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTRKKLEE |
| Q15654 | Y123 | Sugiyama | TRIP6 OIP1 | tLAELNGGRGHASRRPDRQAyEPPPPPAyRtGsLKPNPAsP |
| Q15785 | Y32 | Sugiyama | TOMM34 URCC3 | LRAAGNESFRNGQyAEASALyGRALRVLQAQGssDPEEEsV |
| Q15818 | Y150 | Sugiyama | NPTX1 | LSQLGQTLQSLKTRLENLEQySRLNSSSQTNSLKDLLQSKI |
| Q15819 | Y143 | Sugiyama | UBE2V2 MMS2 UEV2 | RRLMMSKENMKLPQPPEGQtyNN__________________ |
| Q16181 | Y306 | Sugiyama | SEPTIN7 CDC10 SEPT7 | RNMLIRTHMQDLKDVTNNVHyENyRSRKLAAVtyNGVDNNK |
| Q16543 | Y248 | Sugiyama | CDC37 CDC37A | VDPRACFRQFFTKIKtADRQyMEGFNDELEAFKERVRGRAK |
| Q16576 | Y153 | Sugiyama | RBBP7 RBAP46 | PQNPHIIATKtPssDVLVFDyTKHPAKPDPsGECNPDLRLR |
| Q16643 | Y163 | Sugiyama | DBN1 D0S117E | PVLHRLRLREDENAEPVGttyQKTDAAVEMKRINREQFWEQ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16719 | Y86 | Sugiyama | KYNU | ENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVGK |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q16881 | Y277 | Sugiyama | TXNRD1 GRIM12 KDRF | NHIGSLNWGYRVALREKKVVyENAyGQFIGPHRIKATNNKG |
| Q16881 | Y281 | Sugiyama | TXNRD1 GRIM12 KDRF | SLNWGYRVALREKKVVyENAyGQFIGPHRIKATNNKGKEKI |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | S258 | Sugiyama | HSP90AB2P HSP90BB | LAVRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQ |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5F1R6 | Y5 | Sugiyama | DNAJC21 DNAJA5 | ________________MKCHyEALGVRRDASEEELKKAYRK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5VTE0 | Y254 | Sugiyama | EEF1A1P5 EEF1AL3 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q66LE6 | Y80 | Sugiyama | PPP2R2D KIAA1541 | IFQREQENKSRPHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6FI81 | Y278 | Sugiyama | CIAPIN1 CUA001 PRO0915 | EKEKSREQMSSQPKsACGNCyLGDAFRCAsCPyLGMPAFKP |
| Q6NW29 | Y18 | Sugiyama | RWDD4 FAM28A RWDD4A | ___MsANEDQEMELEALRSIyEGDEsFRELsPVSFQyRIGE |
| Q6P1L8 | Y51 | Sugiyama | MRPL14 MRPL32 RPML32 | AIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKVGD |
| Q6PEY2 | T225 | Sugiyama | TUBA3E | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y791 | Sugiyama | POTEE A26C1A POTE2 | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | T225 | Sugiyama | TUBA1A TUBA3 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q71U36 | T94 | Sugiyama | TUBA1A TUBA3 | VIDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| Q71U36 | Y103 | Sugiyama | TUBA1A TUBA3 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q7KZF4 | Y728 | Sugiyama | SND1 TDRD11 | EKLMENMRNDIAsHPPVEGsyAPRRGEFCIAKFVDGEWYRA |
| Q7RTV0 | Y100 | Sugiyama | PHF5A | KDRDGCPKIVNLGSsKTDLFyERKKYGFKKR__________ |
| Q7RTV0 | Y51 | Sugiyama | PHF5A | VICDSyVRPCTLVRICDECNyGsyQGRCVICGGPGVSDAyy |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q8IWX8 | Y894 | Sugiyama | CHERP DAN26 SCAF6 | GDVRDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDE |
| Q8IWX8 | Y897 | Sugiyama | CHERP DAN26 SCAF6 | RDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDECK_ |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y133 | Sugiyama | PGAM4 PGAM3 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSY |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8N3D4 | Y1362 | Sugiyama | EHBP1L1 | EPPPSPGEEAGLQRFQDtsQyVCAELQALEQEQRQIDGRAA |
| Q8N5M4 | Y11 | Sugiyama | TTC9C | __________MEKRLQEAQLyKEEGNQRYREGKYRDAVSRY |
| Q8N7H5 | Y169 | Sugiyama | PAF1 PD2 | EKPEVKIGVSVKQQFTEEEIyKDRDSQITAIEKTFEDAQKS |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8ND04 | Y634 | Sugiyama | SMG8 ABC2 C17orf71 | GRKQAPRDDPFDIKAANyDFyQLLEEKCCGKLDHINFPVFE |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q8WU90 | Y137 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DKCKFSHDLTLERKCEKRsVyIDARDEELEKDTMDNWDEKK |
| Q8WUM4 | Y39 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | KPLVKFIQQTYPSGGEEQAQyCRAAEELSKLRRAAVGRPLD |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WWM7 | S276 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | MFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRA |
| Q8WWM7 | Y118 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | sARGQstGKGPPQsPVFEGVyNNSRMLHFLTAVVGSTCDVK |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q92499 | Y135 | Sugiyama | DDX1 | EVKEWHGCRATKGLMKGKHyyEVSCHDQGLCRVGWSTMQAS |
| Q92526 | Y109 | Sugiyama | CCT6B | GDGTTSNVLIIGELLKQADLyISEGLHPRIIAEGFEAAKIK |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q92626 | Y916 | Sugiyama | PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1 | SVYPREQINQLtsyIDASNVyGsTEHEARSIRDLASHRGLL |
| Q92769 | S89 | Sugiyama | HDAC2 | HSDEYIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDGLFE |
| Q92769 | Y88 | Sugiyama | HDAC2 | YHSDEYIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDGLF |
| Q92796 | S615 | Sugiyama | DLG3 KIAA1232 | GLSDDYYGAKNLKGQEDAILsYEPVTRQEIHYARPVIILGP |
| Q92796 | Y673 | Sugiyama | DLG3 KIAA1232 | GSCVPHTTRPRRDNEVDGQDyHFVVsREQMEKDIQDNKFIE |
| Q93052 | Y301 | Sugiyama | LPP | LQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQG |
| Q93052 | Y317 | Sugiyama | LPP | yEGyyAAGPGyGGRNDsDPtyGQQGHPNtWKREPGytPPGA |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96AY3 | Y201 | Sugiyama | FKBP10 FKBP65 PSEC0056 | YNGTLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGM |
| Q96AY3 | Y204 | Sugiyama | FKBP10 FKBP65 PSEC0056 | TLLDGTSFDTSYSKGGtyDtyVGsGWLIKGMDQGLLGMCPG |
| Q96B26 | Y14 | Sugiyama | EXOSC8 OIP2 RRP43 | _______MAAGFKTVEPLEyyRRFLKENCRPDGRELGEFRT |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96D46 | Y459 | Sugiyama | NMD3 CGI-07 | YQDFLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRIS |
| Q96DG6 | Y165 | Sugiyama | CMBL | YSEFRAGVSVYGIVKDSEDIyNLKNPTLFIFAENDVVIPLK |
| Q96EP5 | Y405 | Sugiyama | DAZAP1 | PAGGSGFGRGQNHNVQGFHPyRR__________________ |
| Q96FW1 | Y93 | Sugiyama | OTUB1 OTB1 OTU1 HSPC263 | KDLHKKYSYIRKTRPDGNCFyRAFGFSHLEALLDDSKELQR |
| Q96HN2 | Y372 | Sugiyama | AHCYL2 KIAA0828 | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDMMFGG |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96P48 | Y231 | SIGNOR|EPSD|PSP | ARAP1 CENTD2 KIAA0782 | CPPEIPPKPVRLFPEFDDsDyDEVPEEGPGAPARVMTKKEE |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99439 | Y12 | Sugiyama | CNN2 | _________MsstQFNKGPsyGLsAEVKNRLLSKYDPQKEA |
| Q99497 | T140 | Sugiyama | PARK7 | GSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGT |
| Q99497 | Y139 | Sugiyama | PARK7 | FGSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPG |
| Q99497 | Y141 | Sugiyama | PARK7 | SKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGTS |
| Q99538 | Y53 | Sugiyama | LGMN PRSC1 | IVAGSNGWYNYRHQADACHAyQIIHRNGIPDEQIVVMMYDD |
| Q99543 | Y274 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | TRAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAE |
| Q99613 | Y159 | Sugiyama | EIF3C EIF3S8 | STLRQKIRKyNRDFEsHItSyKQNPEQsADEDAEKNEEDsE |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99615 | Y51 | Sugiyama | DNAJC7 TPR2 TTC2 | FKEQGNAYYAKKDYNEAyNyytKAIDMCPKNASYYGNRAAT |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y71 | Sugiyama | ACO2 | NINIVRKRLNRPLTLSEKIVyGHLDDPAsQEIERGKSYLRL |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q9BQE3 | T225 | Sugiyama | TUBA1C TUBA6 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9BQE3 | T94 | Sugiyama | TUBA1C TUBA6 | VIDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| Q9BQE3 | Y103 | Sugiyama | TUBA1C TUBA6 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q9BRL6 | Y44 | Sugiyama | SRSF8 SFRS2B SRP46 | RtsPDsLRRVFEKYGRVGDVyIPREPHTKAPRGFAFVRFHD |
| Q9BS26 | Y135 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | NGMMMKREYRGQRSVKALADyIRQQKSDPIQEIRDLAEItt |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BSU3 | Y145 | Sugiyama | NAA11 ARD1B ARD2 | TLNFQISEVEPKyyADGEDAyAMKRDLSQMADELRRQMDLK |
| Q9BUJ2 | Y510 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | RLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIV |
| Q9BVA1 | Y106 | Sugiyama | TUBB2B | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q9BW91 | Y140 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | FsPKFNEKDGHVERKSKNGLyEIENGRPRNPAGRTGLVGRG |
| Q9BWD1 | Y130 | Sugiyama | ACAT2 ACTL | DSSIVVAGGMENMSKAPHLAyLRTGVKIGEMPLTDSILCDG |
| Q9BXJ9 | Y247 | Sugiyama | NAA15 GA19 NARG1 NATH TBDN100 | EETKGELLLQLCRLEDAADVyRGLQERNPENWAYYKGLEKA |
| Q9BXS5 | Y418 | Sugiyama | AP1M1 CLTNM | IEKSGYQALPWVRYITQNGDyQLRtQ_______________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BYX7 | Y91 | Sugiyama | POTEKP ACTBL3 FKSG30 | MEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAPLN |
| Q9BZI7 | Y167 | Sugiyama | UPF3B RENT3B UPF3X | RDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIEA |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H2U1 | Y169 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NQEKKMFRIRNRsyIDRDsEyLLQENEPDGtLDQKLLEDLQ |
| Q9H3G5 | Y199 | Sugiyama | CPVL VLP PSEC0124 UNQ197/PRO223 | LYSALIQFFQIFPEYKNNDFyVTGESyAGKYVPAIAHLIHS |
| Q9H3P7 | Y492 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | NKPLLDEIVPVYRRDCHEEVyAGSHQYPGRGVYLLKFDNSY |
| Q9H4A3 | Y2102 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | KHLKEIQDLQSRQKHEIEsLyTKLGKVPPAVIIPPAAPLsG |
| Q9H501 | Y72 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | AVDKRGRPISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQK |
| Q9H6F5 | Y109 | Sugiyama | CCDC86 CYCLON | AAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQ |
| Q9H6T3 | Y156 | Sugiyama | RPAP3 | LKEKGNKYFKQGKYDEAIDCytKGMDADPyNPVLPTNRASA |
| Q9H7Z7 | Y308 | Sugiyama | PTGES2 C9orf15 PGES2 | LISKRLKSRHRLQDNVREDLyEAADKWVAAVGKDRPFMGGQ |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HB07 | Y189 | Sugiyama | MYG1 C12orf10 | VEEVDAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHP |
| Q9NPD3 | Y53 | Sugiyama | EXOSC4 RRP41 SKI6 | AQADGSAYIEQGNTKALAVVyGPHEIRGsRARALPDRALVN |
| Q9NQR4 | T205 | Sugiyama | NIT2 CUA002 | PAHWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHSTVV |
| Q9NQR4 | Y202 | Sugiyama | NIT2 CUA002 | TTGPAHWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHS |
| Q9NQW7 | Y296 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | KALCADLsPREKVWVSDKASyAVSETIPKDHRCCMPYTPIC |
| Q9NRY4 | Y1105 | GPS6 | ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP | sDyAEPMDAVVKPRNEEENIysVPHDsTQGKIITIRNINKA |
| Q9NSD9 | Y63 | Sugiyama | FARSB FARSLB FRSB HSPC173 | EIISKEQGNVKAAGASDVVLyKIDVPANRYDLLCLEGLVRG |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NX18 | Y105 | Sugiyama | SDHAF2 C11orf79 PGL2 SDH5 | LLSLFAKEHLQHMTEKQLNLyDRLINEPSNDWDIYYWATEA |
| Q9NY65 | T225 | Sugiyama | TUBA8 TUBAL2 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9NY65 | T94 | Sugiyama | TUBA8 TUBAL2 | VVDEVRAGTYRQLFHPEQLItGKEDAANNyARGHYTVGKES |
| Q9NY65 | Y103 | Sugiyama | TUBA8 TUBAL2 | YRQLFHPEQLItGKEDAANNyARGHYTVGKESIDLVLDRIR |
| Q9NYU2 | Y449 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | IEGLSLHNVLKLNIQPsEADyAVDIRSPAISWVNNLEVDSR |
| Q9NYU2 | Y966 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | LVMKVDALLsAQPKGDPRIEyQFFEDRHSAIKLRPKEGETY |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9P031 | Y97 | Sugiyama | CCDC59 BR22 TAP26 HSPC128 | AQTSLESQFtDRYPDNLKHLyLAEEERHRKQARKVDHPLSE |
| Q9UBQ5 | Y42 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | NPENLAtLERYVETQAKENAyDLEANLAVLKLYQFNPAFFQ |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBT2 | Y159 | Sugiyama | UBA2 SAE2 UBLE1B HRIHFB2115 | SGTAGYLGQVTTIKKGVtECyECHPKPTQRTFPGCtIRNTP |
| Q9UDY2 | Y506 | Sugiyama | TJP2 X104 ZO2 | PQPKAAPRtFLRPsPEDEAIyGPNTKMVRFKKGDSVGLRLA |
| Q9UGI8 | Y251 | Sugiyama | TES | RTQYSCYCCKLSMKEGDPAIyAERAGyDKLWHPACFVCSTC |
| Q9UGK3 | Y250 | SIGNOR|EPSD|PSP | STAP2 BKS | VNYFVSHTKKALVPFLLDEDyEKVLGYVEADKENGENVWVA |
| Q9UHI6 | Y756 | Sugiyama | DDX20 DP103 GEMIN3 | RNLPRRSsFRLQtEAQEDDWyDCHREIRLSFSDTYQDYEEY |
| Q9UHR4 | Y380 | Sugiyama | BAIAP2L1 IRTKS | SFAQGDVITLLIPEEKDGWLyGEHDVSKARGWFPssYTKLL |
| Q9UHX1 | Y274 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | SCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNLFDLGG |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UIA9 | Y1078 | Sugiyama | XPO7 KIAA0745 RANBP16 | FTQNLSAFRREVNDSMKNSTyGVNSNDMMS___________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UJ83 | Y260 | Sugiyama | HACL1 HPCL HPCL2 PHYH2 HSPC279 | YKLPFLPTPMGKGVVPDNHPyCVGAARSRALQFADVIVLFG |
| Q9UKK9 | Y16 | Sugiyama | NUDT5 NUDIX5 HSPC115 | _____MEsQEPtEssQNGKQyIISEELIsEGKWVKLEKTTY |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UMS0 | Y194 | Sugiyama | NFU1 HIRIP5 CGI-33 | KELLDTRIRPTVQEDGGDVIyKGFEDGIVQLKLQGSCTSCP |
| Q9UMS4 | Y108 | Sugiyama | PRPF19 NMP200 PRP19 SNEV | HSFTLRQQLQTTRQELSHALyQHDAACRVIARLTKEVTAAR |
| Q9UN86 | Y20 | Sugiyama | G3BP2 KIAA0660 | _MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSSY |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UQ80 | Y343 | Sugiyama | PA2G4 EBP1 | VLLMPNGPMRITsGPFEPDLyKsEMEVQDAELKALLQssAs |
| Q9UQ80 | Y98 | Sugiyama | PA2G4 EBP1 | TSISVNNCVCHFsPLKSDQDyILKEGDLVKIDLGVHVDGFI |
| Q9Y230 | Y172 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | TGTGSKVGKLTLKTTEMETIyDLGTKMIESLTKDKVQAGDV |
| Q9Y230 | Y446 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IKRVysLFLDEsRSTQYMKEyQDAFLFNELKGEtMDTS___ |
| Q9Y262 | Y247 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | VLNVLHSLVDKSNINRQLEVytsGGDPEsVAGEyGRHSLYK |
| Q9Y262 | Y95 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | QASRVssDVIDQKVyEIQDIyENSWTKLTERFFKNTPWPEA |
| Q9Y265 | Y438 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | KINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKYMK__ |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2B0 | Y71 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKE |
| Q9Y2L1 | T122 | Sugiyama | DIS3 KIAA1008 RRP44 | SAPVYKRIRDVTNNQEKHFytFTNEHHRETYVEQEQGENAN |
| Q9Y2T3 | Y441 | Sugiyama | GDA KIAA1258 | SEAVIQKFLyLGDDRNIEEVyVGGKQVVPFSSsV_______ |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y2X3 | Y428 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | GTGKALAKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQV |
| Q9Y383 | Y173 | Sugiyama | LUC7L2 CGI-59 CGI-74 | QKVMDEVEKARAKKREAEEVyRNsMPASsFQQQKLRVCEVC |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3F4 | Y252 | Sugiyama | STRAP MAWD UNRIP | HPEKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVR |
| Q9Y3F4 | Y300 | Sugiyama | STRAP MAWD UNRIP | yAsGSEDGTLRLWQTVVGKtyGLWKCVLPEEDsGELAKPKI |
| Q9Y3S2 | Y315 | Sugiyama | ZNF330 NOA36 | ssDLFTNLNLGRTYAsGYAHyEEQEN_______________ |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y4L1 | Y116 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | TLRYFQHLLGKQADNPHVALyQARFPEHELTFDPQRQTVHF |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y639 | S213 | Sugiyama | NPTN SDFR1 SDR1 | ATRKNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIE |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | T222 | Sugiyama | CLIC4 | AKKYRNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEI |
| Q9Y696 | Y225 | Sugiyama | CLIC4 | YRNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEIAys |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.523640e-10 | 9.069 | 1 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.489297e-07 | 6.260 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.339935e-07 | 6.363 | 1 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.862245e-06 | 5.164 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.128341e-05 | 4.948 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.126959e-05 | 4.948 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.467982e-05 | 4.833 | 1 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.081329e-05 | 4.682 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.233073e-05 | 4.651 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.609975e-05 | 4.583 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.743060e-05 | 4.427 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.636996e-05 | 4.439 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.551594e-05 | 4.450 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.743060e-05 | 4.427 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.548603e-05 | 4.450 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.328400e-05 | 4.364 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.259847e-05 | 4.371 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.863104e-05 | 4.313 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.872244e-05 | 4.312 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.891124e-05 | 4.230 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.330497e-05 | 4.199 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.192047e-05 | 4.037 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.262492e-04 | 3.899 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.474749e-04 | 3.831 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.742545e-04 | 3.759 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.766312e-04 | 3.753 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.897316e-04 | 3.722 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.893472e-04 | 3.723 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.042016e-04 | 3.690 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.061450e-04 | 3.686 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.755828e-04 | 3.560 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.763425e-04 | 3.559 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.740484e-04 | 3.562 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.159536e-04 | 3.500 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.152671e-04 | 3.501 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.159536e-04 | 3.500 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.189840e-04 | 3.496 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.752696e-04 | 3.426 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.936831e-04 | 3.405 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.809674e-04 | 3.318 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.454594e-04 | 3.263 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.781316e-04 | 3.238 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.517770e-04 | 3.186 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.255358e-04 | 3.139 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.256294e-04 | 3.139 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.050100e-04 | 3.094 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 8.723317e-04 | 3.059 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.010225e-03 | 2.996 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.820620e-04 | 3.008 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.282253e-03 | 2.892 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.386609e-03 | 2.858 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.541469e-03 | 2.812 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.541469e-03 | 2.812 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.623092e-03 | 2.790 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.186968e-03 | 2.660 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.186968e-03 | 2.660 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.124819e-03 | 2.673 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.226509e-03 | 2.652 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.226509e-03 | 2.652 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.226509e-03 | 2.652 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.954733e-03 | 2.529 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.048327e-03 | 2.516 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.135215e-03 | 2.504 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.484014e-03 | 2.458 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.716944e-03 | 2.430 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.830782e-03 | 2.417 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.667094e-03 | 2.436 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.120779e-03 | 2.385 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.812610e-03 | 2.318 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.040960e-03 | 2.297 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.456271e-03 | 2.263 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 5.670585e-03 | 2.246 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.897754e-03 | 2.229 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.303647e-03 | 2.200 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.474897e-03 | 2.189 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.474897e-03 | 2.189 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.599470e-03 | 2.119 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.599470e-03 | 2.119 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.083796e-03 | 2.150 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.692479e-03 | 2.114 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.692479e-03 | 2.114 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.673538e-03 | 2.062 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.123896e-02 | 1.949 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.123896e-02 | 1.949 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.123896e-02 | 1.949 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.123896e-02 | 1.949 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.123896e-02 | 1.949 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.123896e-02 | 1.949 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.123896e-02 | 1.949 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.123896e-02 | 1.949 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.123896e-02 | 1.949 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.123896e-02 | 1.949 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.123896e-02 | 1.949 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.123896e-02 | 1.949 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.123896e-02 | 1.949 | 0 | 0 |
| Defective F9 secretion | R-HSA-9673218 | 1.123896e-02 | 1.949 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.123896e-02 | 1.949 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.123896e-02 | 1.949 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.123896e-02 | 1.949 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 9.749090e-03 | 2.011 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.423184e-03 | 2.026 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.749090e-03 | 2.011 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.023820e-02 | 1.990 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.987659e-03 | 2.046 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.987659e-03 | 2.046 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.031031e-03 | 2.044 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.034116e-02 | 1.985 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.122370e-02 | 1.950 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.163169e-02 | 1.934 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.202159e-02 | 1.920 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.232547e-02 | 1.909 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.278994e-02 | 1.893 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.444556e-02 | 1.840 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.391609e-02 | 1.856 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.376611e-02 | 1.861 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.386185e-02 | 1.858 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.260877e-02 | 1.899 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.396895e-02 | 1.855 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.470944e-02 | 1.832 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.577175e-02 | 1.802 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 1.618840e-02 | 1.791 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.618840e-02 | 1.791 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.622129e-02 | 1.790 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.720865e-02 | 1.764 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.763073e-02 | 1.754 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.896852e-02 | 1.722 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.992715e-02 | 1.701 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.191889e-02 | 1.659 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.391099e-02 | 1.621 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.170009e-02 | 1.664 | 1 | 1 |
| G1 Phase | R-HSA-69236 | 2.170009e-02 | 1.664 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 2.273763e-02 | 1.643 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 2.273763e-02 | 1.643 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.170009e-02 | 1.664 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.391099e-02 | 1.621 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.063872e-02 | 1.685 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.279085e-02 | 1.642 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.398946e-02 | 1.620 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.398946e-02 | 1.620 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.459344e-02 | 1.609 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.504929e-02 | 1.601 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.613687e-02 | 1.583 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.835915e-02 | 1.547 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.835915e-02 | 1.547 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.835915e-02 | 1.547 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.835915e-02 | 1.547 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.835915e-02 | 1.547 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.934880e-02 | 1.532 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.934880e-02 | 1.532 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.025794e-02 | 1.519 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 3.025794e-02 | 1.519 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.334139e-02 | 1.477 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.545604e-02 | 1.450 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.545604e-02 | 1.450 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.795879e-02 | 1.421 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.406000e-02 | 1.468 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.545604e-02 | 1.450 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.672015e-02 | 1.435 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.795879e-02 | 1.421 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.302062e-02 | 1.481 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.065437e-02 | 1.514 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.795879e-02 | 1.421 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.545604e-02 | 1.450 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.182375e-02 | 1.497 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.406000e-02 | 1.468 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.079583e-02 | 1.512 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.672015e-02 | 1.435 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.795879e-02 | 1.421 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.708608e-02 | 1.431 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.708608e-02 | 1.431 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.962881e-02 | 1.402 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.052707e-02 | 1.392 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.265100e-02 | 1.370 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 4.265100e-02 | 1.370 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.315910e-02 | 1.365 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.315910e-02 | 1.365 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.315910e-02 | 1.365 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.420764e-02 | 1.355 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.420764e-02 | 1.355 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.420764e-02 | 1.355 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.420764e-02 | 1.355 | 0 | 0 |
| Defective F9 variant does not activate FX | R-HSA-9673202 | 4.420764e-02 | 1.355 | 0 | 0 |
| Defective cofactor function of FVIIIa variant | R-HSA-9672396 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.420764e-02 | 1.355 | 0 | 0 |
| Defective factor IX causes thrombophilia | R-HSA-9672383 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.420764e-02 | 1.355 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.420764e-02 | 1.355 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.495240e-02 | 1.260 | 0 | 0 |
| Defective CYP19A1 causes AEXS | R-HSA-5579030 | 5.495240e-02 | 1.260 | 0 | 0 |
| Defective gamma-carboxylation of F9 | R-HSA-9673240 | 5.495240e-02 | 1.260 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.585315e-02 | 1.339 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.585315e-02 | 1.339 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.429047e-02 | 1.265 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.429047e-02 | 1.265 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.429047e-02 | 1.265 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.860751e-02 | 1.313 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.069260e-02 | 1.295 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.429047e-02 | 1.265 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.495240e-02 | 1.260 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.721579e-02 | 1.242 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.420430e-02 | 1.355 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.860751e-02 | 1.313 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.872598e-02 | 1.312 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.787665e-02 | 1.237 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.429047e-02 | 1.265 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.589014e-02 | 1.338 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.860751e-02 | 1.313 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.429047e-02 | 1.265 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.019489e-02 | 1.220 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.019489e-02 | 1.220 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.019489e-02 | 1.220 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.019489e-02 | 1.220 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.322618e-02 | 1.199 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.322618e-02 | 1.199 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.322618e-02 | 1.199 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.414380e-02 | 1.193 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.526180e-02 | 1.185 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 6.557703e-02 | 1.183 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.557703e-02 | 1.183 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.557703e-02 | 1.183 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 6.557703e-02 | 1.183 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.557703e-02 | 1.183 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.557703e-02 | 1.183 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 6.557703e-02 | 1.183 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.579419e-02 | 1.182 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.579419e-02 | 1.182 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.608287e-02 | 1.119 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.608287e-02 | 1.119 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 7.608287e-02 | 1.119 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.608287e-02 | 1.119 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.647122e-02 | 1.063 | 1 | 1 |
| STAT5 Activation | R-HSA-9645135 | 9.674341e-02 | 1.014 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.674341e-02 | 1.014 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.069007e-01 | 0.971 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.268758e-01 | 0.897 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.268758e-01 | 0.897 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 1.366961e-01 | 0.864 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.366961e-01 | 0.864 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.366961e-01 | 0.864 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.464065e-01 | 0.834 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.560083e-01 | 0.807 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.655027e-01 | 0.781 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 1.748909e-01 | 0.757 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.748909e-01 | 0.757 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.841740e-01 | 0.735 | 1 | 1 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 1.933532e-01 | 0.714 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.933532e-01 | 0.714 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 1.933532e-01 | 0.714 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.933532e-01 | 0.714 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.933532e-01 | 0.714 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.024297e-01 | 0.694 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.024297e-01 | 0.694 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.024297e-01 | 0.694 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.024297e-01 | 0.694 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.911296e-02 | 1.102 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.067216e-01 | 0.972 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.067216e-01 | 0.972 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.067216e-01 | 0.972 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.139794e-01 | 0.943 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.213602e-01 | 0.916 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.250939e-01 | 0.903 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.879925e-02 | 1.162 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.326422e-01 | 0.877 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.480335e-01 | 0.830 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.637645e-01 | 0.786 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.000995e-01 | 0.699 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.757225e-01 | 0.755 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.933532e-01 | 0.714 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.959610e-02 | 1.002 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.261268e-02 | 1.033 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.655027e-01 | 0.781 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.655027e-01 | 0.781 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.067216e-01 | 0.972 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.250939e-01 | 0.903 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.250939e-01 | 0.903 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.250939e-01 | 0.903 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.319711e-01 | 0.880 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.608287e-02 | 1.119 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 7.608287e-02 | 1.119 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.169444e-01 | 0.932 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.560083e-01 | 0.807 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.933532e-01 | 0.714 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.261808e-02 | 1.139 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.261808e-02 | 1.139 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.917739e-02 | 1.050 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.067216e-01 | 0.972 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.103346e-01 | 0.957 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.098812e-01 | 0.959 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.474898e-01 | 0.831 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.959610e-02 | 1.002 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.024297e-01 | 0.694 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.911296e-02 | 1.102 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.250939e-01 | 0.903 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.169444e-01 | 0.932 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.366961e-01 | 0.864 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.366961e-01 | 0.864 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.464065e-01 | 0.834 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 1.464065e-01 | 0.834 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 1.655027e-01 | 0.781 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.748909e-01 | 0.757 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.933532e-01 | 0.714 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.911296e-02 | 1.102 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.402915e-01 | 0.853 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.069007e-01 | 0.971 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.878686e-01 | 0.726 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.261808e-02 | 1.139 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.069007e-01 | 0.971 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.464065e-01 | 0.834 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.560083e-01 | 0.807 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.655027e-01 | 0.781 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.943927e-02 | 1.158 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.933532e-01 | 0.714 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.933532e-01 | 0.714 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.261268e-02 | 1.033 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.598032e-01 | 0.796 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 1.655027e-01 | 0.781 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.655027e-01 | 0.781 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 8.647122e-02 | 1.063 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.169444e-01 | 0.932 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 1.464065e-01 | 0.834 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 1.560083e-01 | 0.807 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.677432e-01 | 0.775 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.677432e-01 | 0.775 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.495693e-01 | 0.825 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.841740e-01 | 0.735 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.242620e-02 | 1.084 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.578146e-02 | 1.067 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.399307e-01 | 0.854 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.880522e-02 | 1.103 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.608287e-02 | 1.119 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 8.647122e-02 | 1.063 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.069007e-01 | 0.971 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.169444e-01 | 0.932 | 1 | 1 |
| RSK activation | R-HSA-444257 | 1.169444e-01 | 0.932 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 1.464065e-01 | 0.834 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.655027e-01 | 0.781 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.748909e-01 | 0.757 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.838155e-01 | 0.736 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.370779e-01 | 0.863 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.971493e-01 | 0.705 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.959610e-02 | 1.002 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.195751e-02 | 1.086 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.268758e-01 | 0.897 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.933532e-01 | 0.714 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.919342e-01 | 0.717 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.242620e-02 | 1.084 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.054747e-01 | 0.977 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.308213e-01 | 0.883 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.524384e-01 | 0.817 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.560083e-01 | 0.807 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.578146e-02 | 1.067 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.324791e-01 | 0.878 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.069007e-01 | 0.971 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.169444e-01 | 0.932 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.268758e-01 | 0.897 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 1.464065e-01 | 0.834 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.711988e-02 | 1.013 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.905701e-01 | 0.720 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.249166e-01 | 0.903 | 1 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.242620e-02 | 1.084 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.046450e-01 | 0.980 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.261808e-02 | 1.139 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.024297e-01 | 0.694 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.242620e-02 | 1.084 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.364547e-01 | 0.865 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.603899e-02 | 1.018 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.422516e-01 | 0.847 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.603899e-02 | 1.018 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.677432e-01 | 0.775 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.250939e-01 | 0.903 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.169444e-01 | 0.932 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.268758e-01 | 0.897 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.366961e-01 | 0.864 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.933532e-01 | 0.714 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.213602e-01 | 0.916 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.717968e-01 | 0.765 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.578146e-02 | 1.067 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.608287e-02 | 1.119 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 9.674341e-02 | 1.014 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.578146e-02 | 1.067 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.024297e-01 | 0.694 | 0 | 0 |
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | R-HSA-159763 | 9.674341e-02 | 1.014 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 1.069007e-01 | 0.971 | 0 | 0 |
| Gamma-carboxylation of protein precursors | R-HSA-159740 | 1.560083e-01 | 0.807 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 1.655027e-01 | 0.781 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.655027e-01 | 0.781 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.103346e-01 | 0.957 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.268758e-01 | 0.897 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.748909e-01 | 0.757 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.841740e-01 | 0.735 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.933532e-01 | 0.714 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.364547e-01 | 0.865 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.501320e-02 | 1.125 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.838155e-01 | 0.736 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.933532e-01 | 0.714 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.240981e-01 | 0.906 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.829480e-01 | 0.738 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.677432e-01 | 0.775 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.677432e-01 | 0.775 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.302205e-02 | 1.137 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.067216e-01 | 0.972 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.911296e-02 | 1.102 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.402915e-01 | 0.853 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.212081e-01 | 0.916 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.919342e-01 | 0.717 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.176550e-01 | 0.929 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.478194e-01 | 0.830 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.480335e-01 | 0.830 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.821969e-01 | 0.739 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.782360e-01 | 0.749 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.440104e-01 | 0.842 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.000995e-01 | 0.699 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.083053e-01 | 0.681 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.083053e-01 | 0.681 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 2.083053e-01 | 0.681 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.114047e-01 | 0.675 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.114047e-01 | 0.675 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.114047e-01 | 0.675 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.114047e-01 | 0.675 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.114047e-01 | 0.675 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.114047e-01 | 0.675 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.114047e-01 | 0.675 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 2.114047e-01 | 0.675 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.114047e-01 | 0.675 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.114047e-01 | 0.675 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.124215e-01 | 0.673 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.124215e-01 | 0.673 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.202792e-01 | 0.657 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.202792e-01 | 0.657 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.202792e-01 | 0.657 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.202792e-01 | 0.657 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.202792e-01 | 0.657 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.202792e-01 | 0.657 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.214968e-01 | 0.655 | 1 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.289590e-01 | 0.640 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.290543e-01 | 0.640 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.290543e-01 | 0.640 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.290543e-01 | 0.640 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.290543e-01 | 0.640 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.290543e-01 | 0.640 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.290543e-01 | 0.640 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.290543e-01 | 0.640 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.290543e-01 | 0.640 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.331081e-01 | 0.632 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.372618e-01 | 0.625 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.372618e-01 | 0.625 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.372618e-01 | 0.625 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.372618e-01 | 0.625 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.372618e-01 | 0.625 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.377313e-01 | 0.624 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.377313e-01 | 0.624 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.377313e-01 | 0.624 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.377313e-01 | 0.624 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.377313e-01 | 0.624 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.377313e-01 | 0.624 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 2.377313e-01 | 0.624 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 2.377313e-01 | 0.624 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 2.377313e-01 | 0.624 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.414196e-01 | 0.617 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.414196e-01 | 0.617 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.441696e-01 | 0.612 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.455807e-01 | 0.610 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.455807e-01 | 0.610 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.463111e-01 | 0.609 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.463111e-01 | 0.609 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.463111e-01 | 0.609 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.463111e-01 | 0.609 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.463111e-01 | 0.609 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 2.463111e-01 | 0.609 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.463111e-01 | 0.609 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 2.463111e-01 | 0.609 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.463111e-01 | 0.609 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.488001e-01 | 0.604 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 2.539107e-01 | 0.595 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.547949e-01 | 0.594 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.547949e-01 | 0.594 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 2.547949e-01 | 0.594 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.547949e-01 | 0.594 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.547949e-01 | 0.594 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.547949e-01 | 0.594 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.547949e-01 | 0.594 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.547949e-01 | 0.594 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.572427e-01 | 0.590 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.580784e-01 | 0.588 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.622472e-01 | 0.581 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.622472e-01 | 0.581 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.631837e-01 | 0.580 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.631837e-01 | 0.580 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.631837e-01 | 0.580 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.631837e-01 | 0.580 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.631837e-01 | 0.580 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.631837e-01 | 0.580 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.652817e-01 | 0.576 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.664165e-01 | 0.574 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.682140e-01 | 0.572 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.705858e-01 | 0.568 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.705858e-01 | 0.568 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.714786e-01 | 0.566 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.714786e-01 | 0.566 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.714786e-01 | 0.566 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.714786e-01 | 0.566 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 2.714786e-01 | 0.566 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.714786e-01 | 0.566 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.789222e-01 | 0.555 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.796806e-01 | 0.553 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.796806e-01 | 0.553 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.796806e-01 | 0.553 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.796806e-01 | 0.553 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.796806e-01 | 0.553 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 2.796806e-01 | 0.553 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.796806e-01 | 0.553 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.830884e-01 | 0.548 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.831749e-01 | 0.548 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.835573e-01 | 0.547 | 1 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.872525e-01 | 0.542 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.872525e-01 | 0.542 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.877907e-01 | 0.541 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.877907e-01 | 0.541 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.877907e-01 | 0.541 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.877907e-01 | 0.541 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.877907e-01 | 0.541 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.877907e-01 | 0.541 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.877907e-01 | 0.541 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.896752e-01 | 0.538 | 1 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.896752e-01 | 0.538 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 2.910599e-01 | 0.536 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.914141e-01 | 0.535 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.914141e-01 | 0.535 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.914141e-01 | 0.535 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.955727e-01 | 0.529 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.958101e-01 | 0.529 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.958101e-01 | 0.529 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.958101e-01 | 0.529 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.958101e-01 | 0.529 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.037396e-01 | 0.517 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.037396e-01 | 0.517 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.037396e-01 | 0.517 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.037396e-01 | 0.517 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.037396e-01 | 0.517 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.037396e-01 | 0.517 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.037396e-01 | 0.517 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.037396e-01 | 0.517 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.050099e-01 | 0.516 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.080260e-01 | 0.511 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.115804e-01 | 0.506 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.115804e-01 | 0.506 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.115804e-01 | 0.506 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.115804e-01 | 0.506 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.116045e-01 | 0.506 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.163053e-01 | 0.500 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.173044e-01 | 0.499 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.193333e-01 | 0.496 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.193333e-01 | 0.496 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.193333e-01 | 0.496 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.193333e-01 | 0.496 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.193333e-01 | 0.496 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.193333e-01 | 0.496 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.193333e-01 | 0.496 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.255550e-01 | 0.487 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.269994e-01 | 0.485 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.269994e-01 | 0.485 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.269994e-01 | 0.485 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.269994e-01 | 0.485 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.286813e-01 | 0.483 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.327937e-01 | 0.478 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.345796e-01 | 0.476 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.345796e-01 | 0.476 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.345796e-01 | 0.476 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.345796e-01 | 0.476 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.345796e-01 | 0.476 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.345796e-01 | 0.476 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.388349e-01 | 0.470 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.388936e-01 | 0.470 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.398976e-01 | 0.469 | 1 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.420749e-01 | 0.466 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.420749e-01 | 0.466 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.420749e-01 | 0.466 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.420749e-01 | 0.466 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.420749e-01 | 0.466 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.450870e-01 | 0.462 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 3.490429e-01 | 0.457 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.494862e-01 | 0.457 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.532423e-01 | 0.452 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.568145e-01 | 0.448 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.568145e-01 | 0.448 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.568145e-01 | 0.448 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.568145e-01 | 0.448 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.568145e-01 | 0.448 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.568145e-01 | 0.448 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.640607e-01 | 0.439 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.640607e-01 | 0.439 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.640607e-01 | 0.439 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.640607e-01 | 0.439 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.640607e-01 | 0.439 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.654084e-01 | 0.437 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.669737e-01 | 0.435 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.695116e-01 | 0.432 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.695116e-01 | 0.432 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.712257e-01 | 0.430 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.712257e-01 | 0.430 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.712257e-01 | 0.430 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.712257e-01 | 0.430 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.734711e-01 | 0.428 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.774871e-01 | 0.423 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.774871e-01 | 0.423 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.814925e-01 | 0.419 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.853157e-01 | 0.414 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.853157e-01 | 0.414 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.853157e-01 | 0.414 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.853157e-01 | 0.414 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.853157e-01 | 0.414 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.894706e-01 | 0.410 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.894706e-01 | 0.410 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.894706e-01 | 0.410 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.908444e-01 | 0.408 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.922425e-01 | 0.406 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.922425e-01 | 0.406 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.934427e-01 | 0.405 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.974031e-01 | 0.401 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.990917e-01 | 0.399 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.990917e-01 | 0.399 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.013518e-01 | 0.396 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.013518e-01 | 0.396 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.058641e-01 | 0.392 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.058641e-01 | 0.392 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.092125e-01 | 0.388 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.092125e-01 | 0.388 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.092125e-01 | 0.388 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.125605e-01 | 0.385 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.125605e-01 | 0.385 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.125605e-01 | 0.385 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.125605e-01 | 0.385 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.125605e-01 | 0.385 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.125605e-01 | 0.385 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.125605e-01 | 0.385 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.170231e-01 | 0.380 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.191820e-01 | 0.378 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.191820e-01 | 0.378 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.191820e-01 | 0.378 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.191820e-01 | 0.378 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.239869e-01 | 0.373 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.257292e-01 | 0.371 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.257292e-01 | 0.371 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.257292e-01 | 0.371 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.286413e-01 | 0.368 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.292428e-01 | 0.367 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.322030e-01 | 0.364 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.322030e-01 | 0.364 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.322030e-01 | 0.364 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.388547e-01 | 0.358 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.401377e-01 | 0.356 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.449336e-01 | 0.352 | 1 | 1 |
| Netrin-1 signaling | R-HSA-373752 | 4.449336e-01 | 0.352 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.449336e-01 | 0.352 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.477318e-01 | 0.349 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.511921e-01 | 0.346 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.511921e-01 | 0.346 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.511921e-01 | 0.346 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.511921e-01 | 0.346 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.515073e-01 | 0.345 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.515073e-01 | 0.345 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 4.535774e-01 | 0.343 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.573804e-01 | 0.340 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.573804e-01 | 0.340 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.627459e-01 | 0.335 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.634992e-01 | 0.334 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.634992e-01 | 0.334 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.729412e-01 | 0.325 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.755319e-01 | 0.323 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.755319e-01 | 0.323 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.755319e-01 | 0.323 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.755319e-01 | 0.323 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.765233e-01 | 0.322 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.775201e-01 | 0.321 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.775201e-01 | 0.321 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.795906e-01 | 0.319 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.811752e-01 | 0.318 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.814472e-01 | 0.317 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.817494e-01 | 0.317 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.930795e-01 | 0.307 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.930795e-01 | 0.307 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.930795e-01 | 0.307 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.930795e-01 | 0.307 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.930795e-01 | 0.307 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.987979e-01 | 0.302 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.987979e-01 | 0.302 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.987979e-01 | 0.302 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.987979e-01 | 0.302 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.987979e-01 | 0.302 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.987979e-01 | 0.302 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.027737e-01 | 0.299 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.044522e-01 | 0.297 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 5.051680e-01 | 0.297 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.100430e-01 | 0.292 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.155712e-01 | 0.288 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.155712e-01 | 0.288 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.155712e-01 | 0.288 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.264420e-01 | 0.279 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.272326e-01 | 0.278 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.317861e-01 | 0.274 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.317861e-01 | 0.274 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.317861e-01 | 0.274 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.317861e-01 | 0.274 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.317861e-01 | 0.274 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.317861e-01 | 0.274 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.317861e-01 | 0.274 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.327352e-01 | 0.273 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.370702e-01 | 0.270 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.370702e-01 | 0.270 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.370702e-01 | 0.270 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.370702e-01 | 0.270 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.370702e-01 | 0.270 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.370702e-01 | 0.270 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.381331e-01 | 0.269 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.408420e-01 | 0.267 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.422949e-01 | 0.266 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.422949e-01 | 0.266 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.422949e-01 | 0.266 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.439719e-01 | 0.264 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.474611e-01 | 0.262 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.474611e-01 | 0.262 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.474611e-01 | 0.262 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.474611e-01 | 0.262 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.475451e-01 | 0.262 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.525692e-01 | 0.258 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.576200e-01 | 0.254 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.724347e-01 | 0.242 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 5.724347e-01 | 0.242 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.724347e-01 | 0.242 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.736718e-01 | 0.241 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.768600e-01 | 0.239 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.768600e-01 | 0.239 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.800308e-01 | 0.237 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.831843e-01 | 0.234 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.867559e-01 | 0.232 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.867559e-01 | 0.232 | 1 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.894393e-01 | 0.230 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.914228e-01 | 0.228 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.914228e-01 | 0.228 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.914228e-01 | 0.228 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.914228e-01 | 0.228 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.914228e-01 | 0.228 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.914228e-01 | 0.228 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.960373e-01 | 0.225 | 1 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.960373e-01 | 0.225 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.960373e-01 | 0.225 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.960373e-01 | 0.225 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.006000e-01 | 0.221 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 6.006000e-01 | 0.221 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.095721e-01 | 0.215 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.139827e-01 | 0.212 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.226558e-01 | 0.206 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.226558e-01 | 0.206 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 6.269194e-01 | 0.203 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.311351e-01 | 0.200 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.353034e-01 | 0.197 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.515134e-01 | 0.186 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 6.593476e-01 | 0.181 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.670066e-01 | 0.176 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.670066e-01 | 0.176 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.744944e-01 | 0.171 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.889713e-01 | 0.162 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.927208e-01 | 0.159 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.929210e-01 | 0.159 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.061700e-01 | 0.151 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.094945e-01 | 0.149 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.096751e-01 | 0.149 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 7.127816e-01 | 0.147 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.160317e-01 | 0.145 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.192452e-01 | 0.143 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 7.317417e-01 | 0.136 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.407496e-01 | 0.130 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.429538e-01 | 0.129 | 1 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.436849e-01 | 0.129 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.465871e-01 | 0.127 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 7.494567e-01 | 0.125 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.633268e-01 | 0.117 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.767122e-01 | 0.110 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.831137e-01 | 0.106 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.888173e-01 | 0.103 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.892039e-01 | 0.103 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.912110e-01 | 0.102 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 7.921667e-01 | 0.101 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.959178e-01 | 0.099 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.092823e-01 | 0.092 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.094143e-01 | 0.092 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.189420e-01 | 0.087 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.240421e-01 | 0.084 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.260385e-01 | 0.083 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.280125e-01 | 0.082 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.299641e-01 | 0.081 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.311429e-01 | 0.080 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.372391e-01 | 0.077 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.375529e-01 | 0.077 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.383894e-01 | 0.077 | 1 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.465668e-01 | 0.072 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 8.520481e-01 | 0.070 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.534183e-01 | 0.069 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.599656e-01 | 0.066 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.644863e-01 | 0.063 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 8.660010e-01 | 0.062 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.662219e-01 | 0.062 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.779126e-01 | 0.057 | 0 | 0 |
| Translation | R-HSA-72766 | 8.858759e-01 | 0.053 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.873051e-01 | 0.052 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.898541e-01 | 0.051 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.947815e-01 | 0.048 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.994895e-01 | 0.046 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.061616e-01 | 0.043 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.071840e-01 | 0.042 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.072300e-01 | 0.042 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.191447e-01 | 0.037 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.200660e-01 | 0.036 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.200660e-01 | 0.036 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.236480e-01 | 0.034 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.413544e-01 | 0.026 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.458837e-01 | 0.024 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.595275e-01 | 0.018 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.607765e-01 | 0.017 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.734858e-01 | 0.012 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.794298e-01 | 0.009 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.801302e-01 | 0.009 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.818840e-01 | 0.008 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.823672e-01 | 0.008 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.876320e-01 | 0.005 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.909549e-01 | 0.004 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.916604e-01 | 0.004 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.937617e-01 | 0.003 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.941140e-01 | 0.003 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.960541e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.968723e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.990238e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.993697e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.998665e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999612e-01 | 0.000 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Down-Regulation | R-HSA-8849472 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Expression | R-HSA-8849473 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.000000e+00 | 0.000 | 1 | 1 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.551115e-16 | 15.256 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.661338e-16 | 15.176 | 1 | 0 |
| M Phase | R-HSA-68886 | 3.663736e-15 | 14.436 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.328271e-15 | 14.199 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.398082e-14 | 13.620 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.485301e-14 | 13.348 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.252154e-14 | 13.371 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.896883e-14 | 13.409 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.118128e-14 | 13.291 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.794565e-14 | 13.168 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 8.482104e-14 | 13.071 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.536816e-14 | 13.021 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.947598e-14 | 13.002 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.345590e-13 | 12.871 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.754463e-13 | 12.560 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.754463e-13 | 12.560 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.548584e-13 | 12.342 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.160317e-13 | 12.287 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.262768e-13 | 12.203 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.004752e-12 | 11.998 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.238232e-12 | 11.907 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.242340e-12 | 11.906 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.328604e-12 | 11.877 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.328604e-12 | 11.877 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.573519e-12 | 11.803 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.631695e-12 | 11.787 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.426837e-12 | 11.615 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.773670e-12 | 11.557 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.773670e-12 | 11.557 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.995049e-12 | 11.524 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.662071e-12 | 11.436 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.508505e-12 | 11.346 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.592993e-12 | 11.338 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.856871e-12 | 11.232 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.856871e-12 | 11.232 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.134537e-12 | 11.212 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.687317e-12 | 11.175 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.332690e-12 | 11.135 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.954659e-12 | 11.158 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.358891e-12 | 11.133 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.426393e-12 | 11.129 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.114265e-12 | 11.040 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.782952e-12 | 11.010 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.027556e-11 | 10.988 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.141898e-11 | 10.942 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.174938e-11 | 10.930 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.174938e-11 | 10.930 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.257217e-11 | 10.901 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.466716e-11 | 10.834 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.134404e-11 | 10.671 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.253520e-11 | 10.647 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.253520e-11 | 10.647 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.583100e-11 | 10.588 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.774692e-11 | 10.557 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.843636e-11 | 10.546 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.363776e-11 | 10.473 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.497591e-11 | 10.456 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.139245e-11 | 10.383 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.154121e-11 | 10.382 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.154121e-11 | 10.382 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.670730e-11 | 10.331 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.670730e-11 | 10.331 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.453637e-11 | 10.351 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.670730e-11 | 10.331 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.973688e-11 | 10.224 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.246637e-11 | 10.204 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.392065e-11 | 10.131 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.144085e-11 | 10.089 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.487466e-11 | 10.071 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.017804e-10 | 9.992 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.049099e-10 | 9.979 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.518331e-10 | 9.819 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.423247e-10 | 9.847 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.423247e-10 | 9.847 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.796001e-10 | 9.746 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.803360e-10 | 9.744 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.825705e-10 | 9.739 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.135573e-10 | 9.670 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.416655e-10 | 9.617 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.521758e-10 | 9.598 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.521758e-10 | 9.598 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.562925e-10 | 9.591 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.175559e-10 | 9.498 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.803771e-10 | 9.420 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.812820e-10 | 9.419 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.085037e-10 | 9.389 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.563071e-10 | 9.255 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.918794e-10 | 9.160 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.834389e-10 | 9.106 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.019422e-09 | 8.992 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.127521e-09 | 8.948 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.329778e-09 | 8.876 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.568178e-09 | 8.805 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.748578e-09 | 8.757 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.131302e-09 | 8.671 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.234066e-09 | 8.651 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.281821e-09 | 8.642 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.281821e-09 | 8.642 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.599512e-09 | 8.585 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.956219e-09 | 8.529 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.223868e-09 | 8.492 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.223868e-09 | 8.492 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.223868e-09 | 8.492 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.857305e-09 | 8.414 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.862188e-09 | 8.313 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.855861e-09 | 8.232 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.176600e-09 | 8.209 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.342021e-09 | 8.198 | 1 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.607286e-09 | 8.180 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.799794e-09 | 8.108 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.156634e-09 | 8.145 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.799794e-09 | 8.108 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.799794e-09 | 8.108 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.746163e-09 | 8.058 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.597865e-09 | 8.018 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.108765e-08 | 7.955 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.223082e-08 | 7.913 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.307253e-08 | 7.884 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.400194e-08 | 7.854 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.683727e-08 | 7.774 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.878408e-08 | 7.726 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.878408e-08 | 7.726 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.925780e-08 | 7.715 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.016622e-08 | 7.695 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.363170e-08 | 7.627 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.558923e-08 | 7.592 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.830251e-08 | 7.548 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.121601e-08 | 7.506 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.450934e-08 | 7.462 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.804515e-08 | 7.420 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.318689e-08 | 7.365 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.446218e-08 | 7.352 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.143950e-08 | 7.289 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.455711e-08 | 7.263 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.563301e-08 | 7.255 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.541161e-08 | 7.184 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.652267e-08 | 7.116 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.745692e-08 | 7.111 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.561119e-08 | 7.019 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.561119e-08 | 7.019 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.636530e-08 | 7.016 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.636530e-08 | 7.016 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.636530e-08 | 7.016 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.027355e-07 | 6.988 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.072584e-07 | 6.970 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.094050e-07 | 6.961 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.145979e-07 | 6.941 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.155036e-07 | 6.937 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.238661e-07 | 6.907 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.238661e-07 | 6.907 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.503495e-07 | 6.823 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.465986e-07 | 6.834 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.641698e-07 | 6.785 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.641698e-07 | 6.785 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.735815e-07 | 6.760 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.314341e-07 | 6.636 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.403301e-07 | 6.619 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.580696e-07 | 6.588 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.299269e-07 | 6.482 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.330267e-07 | 6.478 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.971427e-07 | 6.401 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.485212e-07 | 6.348 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.503759e-07 | 6.346 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.341781e-07 | 6.272 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.418610e-07 | 6.266 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.457294e-07 | 6.263 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.565101e-07 | 6.255 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.959071e-07 | 6.225 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.068506e-07 | 6.151 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.843814e-07 | 6.105 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.330373e-07 | 6.079 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.330373e-07 | 6.079 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.379493e-06 | 5.860 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.590762e-06 | 5.798 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.594186e-06 | 5.797 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.704099e-06 | 5.769 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.079671e-06 | 5.682 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.494154e-06 | 5.603 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.608296e-06 | 5.584 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.613463e-06 | 5.583 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.065861e-06 | 5.513 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.679735e-06 | 5.434 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.683624e-06 | 5.434 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.396570e-06 | 5.357 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.991167e-06 | 5.302 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.982736e-06 | 5.223 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.414481e-06 | 5.193 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.033387e-05 | 4.986 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.044332e-05 | 4.981 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.304394e-05 | 4.885 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.506804e-05 | 4.822 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.656130e-05 | 4.781 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.899980e-05 | 4.721 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.959508e-05 | 4.529 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.198385e-05 | 4.495 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.342326e-05 | 4.476 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.230058e-05 | 4.374 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.680132e-05 | 4.330 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.224570e-05 | 4.282 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.096775e-05 | 4.215 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.182280e-05 | 4.087 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.444736e-05 | 4.073 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.476595e-05 | 4.023 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.497941e-05 | 4.022 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.853770e-05 | 4.006 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.129265e-04 | 3.947 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.147097e-04 | 3.940 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.300926e-04 | 3.886 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.481623e-04 | 3.829 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.726568e-04 | 3.763 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.103158e-04 | 3.677 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.872379e-04 | 3.542 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.921262e-04 | 3.534 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.040666e-04 | 3.517 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.461741e-04 | 3.461 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.761117e-04 | 3.425 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.407180e-04 | 3.356 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.443418e-04 | 3.352 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.955683e-04 | 3.225 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.623327e-04 | 3.064 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.623327e-04 | 3.064 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.215474e-04 | 3.085 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.552366e-04 | 3.122 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.623327e-04 | 3.064 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.810220e-04 | 3.055 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.987461e-04 | 3.098 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.784608e-04 | 3.056 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.811998e-04 | 3.008 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.957178e-04 | 3.002 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 1.158397e-03 | 2.936 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.167299e-03 | 2.933 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.207504e-03 | 2.918 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.307011e-03 | 2.884 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.408485e-03 | 2.851 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.408485e-03 | 2.851 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.409677e-03 | 2.851 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.572605e-03 | 2.803 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.832678e-03 | 2.737 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.870438e-03 | 2.728 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.054522e-03 | 2.687 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.236223e-03 | 2.650 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.337205e-03 | 2.631 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.337205e-03 | 2.631 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.416968e-03 | 2.617 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.416968e-03 | 2.617 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.704057e-03 | 2.568 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.986522e-03 | 2.525 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.052931e-03 | 2.515 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.117183e-03 | 2.506 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.427564e-03 | 2.465 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.435663e-03 | 2.464 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.565085e-03 | 2.448 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.174150e-03 | 2.379 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.541215e-03 | 2.343 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.863990e-03 | 2.313 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.867434e-03 | 2.313 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.054951e-03 | 2.296 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.442242e-03 | 2.264 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.525081e-03 | 2.258 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.694855e-03 | 2.245 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.960478e-03 | 2.225 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.572886e-03 | 2.182 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.776402e-03 | 2.169 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.158842e-03 | 2.145 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.325275e-03 | 2.080 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.456666e-03 | 2.073 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.456666e-03 | 2.073 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.768367e-03 | 2.057 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.853490e-03 | 2.053 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.277992e-03 | 2.033 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.340498e-03 | 2.030 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.516028e-03 | 2.022 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.577511e-03 | 2.019 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.577511e-03 | 2.019 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.577511e-03 | 2.019 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.631704e-03 | 2.016 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.851575e-03 | 2.006 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.032713e-02 | 1.986 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.105100e-02 | 1.957 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.130036e-02 | 1.947 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.130036e-02 | 1.947 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.130036e-02 | 1.947 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.130036e-02 | 1.947 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.130036e-02 | 1.947 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.130036e-02 | 1.947 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.134123e-02 | 1.945 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.151223e-02 | 1.939 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.292334e-02 | 1.889 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.292334e-02 | 1.889 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.459565e-02 | 1.836 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.459565e-02 | 1.836 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.692863e-02 | 1.771 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.423451e-02 | 1.847 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.292334e-02 | 1.889 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.292334e-02 | 1.889 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.292334e-02 | 1.889 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.755403e-02 | 1.756 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.797712e-02 | 1.745 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.422549e-02 | 1.847 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.300168e-02 | 1.886 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.339511e-02 | 1.873 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.600118e-02 | 1.796 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.630300e-02 | 1.788 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.793978e-02 | 1.746 | 1 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.600118e-02 | 1.796 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.443598e-02 | 1.841 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.887220e-02 | 1.724 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.887220e-02 | 1.724 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.971635e-02 | 1.705 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.975026e-02 | 1.704 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.013178e-02 | 1.696 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.025288e-02 | 1.694 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.093434e-02 | 1.679 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.200995e-02 | 1.657 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.214308e-02 | 1.655 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.311527e-02 | 1.636 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.423387e-02 | 1.616 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.423387e-02 | 1.616 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.425030e-02 | 1.615 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.425030e-02 | 1.615 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.425030e-02 | 1.615 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.425030e-02 | 1.615 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.448798e-02 | 1.611 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.640211e-02 | 1.578 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.640211e-02 | 1.578 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.640211e-02 | 1.578 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.660940e-02 | 1.575 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.660940e-02 | 1.575 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.660940e-02 | 1.575 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.864581e-02 | 1.543 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 2.908697e-02 | 1.536 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.037004e-02 | 1.518 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.096300e-02 | 1.509 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.096300e-02 | 1.509 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.096300e-02 | 1.509 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.168255e-02 | 1.499 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.168255e-02 | 1.499 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.267973e-02 | 1.486 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.335176e-02 | 1.477 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.352148e-02 | 1.475 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.352148e-02 | 1.475 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.581019e-02 | 1.446 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.581019e-02 | 1.446 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.581019e-02 | 1.446 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.581019e-02 | 1.446 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.581019e-02 | 1.446 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.667583e-02 | 1.436 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.694011e-02 | 1.433 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.722508e-02 | 1.429 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.722508e-02 | 1.429 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.722508e-02 | 1.429 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.771697e-02 | 1.423 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.833643e-02 | 1.416 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.833643e-02 | 1.416 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.833643e-02 | 1.416 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.833643e-02 | 1.416 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.877499e-02 | 1.411 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.094170e-02 | 1.388 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.358506e-02 | 1.361 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.358506e-02 | 1.361 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.444506e-02 | 1.352 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.444506e-02 | 1.352 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.444506e-02 | 1.352 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.444506e-02 | 1.352 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.444506e-02 | 1.352 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.630389e-02 | 1.334 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.630389e-02 | 1.334 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.630389e-02 | 1.334 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.630389e-02 | 1.334 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.908341e-02 | 1.309 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.968831e-02 | 1.304 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.137244e-02 | 1.289 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.137244e-02 | 1.289 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.192191e-02 | 1.285 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 5.406446e-02 | 1.267 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.481773e-02 | 1.261 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.481773e-02 | 1.261 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.481773e-02 | 1.261 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.481773e-02 | 1.261 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.481773e-02 | 1.261 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.524584e-02 | 1.258 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.592520e-02 | 1.181 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.648449e-02 | 1.116 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 8.692507e-02 | 1.061 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.692507e-02 | 1.061 | 1 | 1 |
| Uncoating of the HIV Virion | R-HSA-162585 | 9.724824e-02 | 1.012 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.724824e-02 | 1.012 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 9.724824e-02 | 1.012 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 1.074553e-01 | 0.969 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.074553e-01 | 0.969 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.776923e-02 | 1.238 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.776923e-02 | 1.238 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.077479e-02 | 1.216 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.005096e-01 | 0.998 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.985671e-02 | 1.098 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.005096e-01 | 0.998 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.697092e-02 | 1.013 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.005096e-01 | 0.998 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.052494e-02 | 1.043 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.694178e-02 | 1.174 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.216896e-02 | 1.142 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.648449e-02 | 1.116 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.383282e-02 | 1.195 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.692507e-02 | 1.061 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.692507e-02 | 1.061 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.074553e-01 | 0.969 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.658131e-02 | 1.063 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.040838e-01 | 0.983 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.466280e-02 | 1.072 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.077479e-02 | 1.216 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 6.069915e-02 | 1.217 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.319792e-02 | 1.080 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.000549e-02 | 1.046 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.673610e-02 | 1.115 | 1 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.107029e-01 | 0.956 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.592520e-02 | 1.181 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.658131e-02 | 1.063 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.005096e-01 | 0.998 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.985671e-02 | 1.098 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.319792e-02 | 1.080 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 8.692507e-02 | 1.061 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.724824e-02 | 1.012 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.757687e-02 | 1.240 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.757687e-02 | 1.240 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.077479e-02 | 1.216 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.980769e-02 | 1.098 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.005096e-01 | 0.998 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.692507e-02 | 1.061 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.724824e-02 | 1.012 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.391846e-02 | 1.194 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.076923e-01 | 0.968 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.346876e-02 | 1.197 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.077479e-02 | 1.216 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.383282e-02 | 1.195 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.319792e-02 | 1.080 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.077479e-02 | 1.216 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.319792e-02 | 1.080 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.273726e-02 | 1.033 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.773993e-02 | 1.169 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.330638e-02 | 1.135 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.346913e-02 | 1.029 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.648449e-02 | 1.116 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.985671e-02 | 1.098 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.694178e-02 | 1.174 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.655906e-02 | 1.116 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.655906e-02 | 1.116 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.658131e-02 | 1.063 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.799549e-02 | 1.237 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.568655e-02 | 1.121 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.697092e-02 | 1.013 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.112149e-01 | 0.954 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.113340e-01 | 0.953 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.125539e-01 | 0.949 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.150076e-01 | 0.939 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.160402e-01 | 0.935 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 1.175476e-01 | 0.930 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 1.175476e-01 | 0.930 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.175476e-01 | 0.930 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.175476e-01 | 0.930 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.175476e-01 | 0.930 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.181889e-01 | 0.927 | 1 | 0 |
| G1 Phase | R-HSA-69236 | 1.187119e-01 | 0.926 | 1 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.187119e-01 | 0.926 | 1 | 1 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.187119e-01 | 0.926 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.224458e-01 | 0.912 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.262082e-01 | 0.899 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.275265e-01 | 0.894 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.275265e-01 | 0.894 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.275265e-01 | 0.894 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.275265e-01 | 0.894 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.275265e-01 | 0.894 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.275265e-01 | 0.894 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.275265e-01 | 0.894 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.275265e-01 | 0.894 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.275265e-01 | 0.894 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.284378e-01 | 0.891 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.348832e-01 | 0.870 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.373930e-01 | 0.862 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.373930e-01 | 0.862 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.373930e-01 | 0.862 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.373930e-01 | 0.862 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.373930e-01 | 0.862 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.373930e-01 | 0.862 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.373930e-01 | 0.862 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.373930e-01 | 0.862 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.398582e-01 | 0.854 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.439028e-01 | 0.842 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.465385e-01 | 0.834 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.471486e-01 | 0.832 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.471486e-01 | 0.832 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.471486e-01 | 0.832 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.471486e-01 | 0.832 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.471486e-01 | 0.832 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.471486e-01 | 0.832 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.491900e-01 | 0.826 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.493192e-01 | 0.826 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.493192e-01 | 0.826 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.519663e-01 | 0.818 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.532508e-01 | 0.815 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.545392e-01 | 0.811 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.545392e-01 | 0.811 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.567945e-01 | 0.805 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.567945e-01 | 0.805 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.567945e-01 | 0.805 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.567945e-01 | 0.805 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.567945e-01 | 0.805 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.567945e-01 | 0.805 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.567945e-01 | 0.805 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.626741e-01 | 0.789 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.626741e-01 | 0.789 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.651627e-01 | 0.782 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.651627e-01 | 0.782 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.663319e-01 | 0.779 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.663319e-01 | 0.779 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.663319e-01 | 0.779 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.663319e-01 | 0.779 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.663319e-01 | 0.779 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.663319e-01 | 0.779 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.663319e-01 | 0.779 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.663319e-01 | 0.779 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.663319e-01 | 0.779 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.663319e-01 | 0.779 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.663319e-01 | 0.779 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.663319e-01 | 0.779 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.757619e-01 | 0.755 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.757619e-01 | 0.755 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.757619e-01 | 0.755 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.757619e-01 | 0.755 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.757619e-01 | 0.755 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.757619e-01 | 0.755 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.777649e-01 | 0.750 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.793311e-01 | 0.746 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.850859e-01 | 0.733 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.850859e-01 | 0.733 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.850859e-01 | 0.733 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.850859e-01 | 0.733 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.850859e-01 | 0.733 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.853515e-01 | 0.732 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.894318e-01 | 0.723 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.894318e-01 | 0.723 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.906572e-01 | 0.720 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.943050e-01 | 0.712 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.943050e-01 | 0.712 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.943050e-01 | 0.712 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.943050e-01 | 0.712 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.943050e-01 | 0.712 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.943050e-01 | 0.712 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.943050e-01 | 0.712 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 1.943050e-01 | 0.712 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.943050e-01 | 0.712 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.943050e-01 | 0.712 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.943050e-01 | 0.712 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 2.034203e-01 | 0.692 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.034203e-01 | 0.692 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.034203e-01 | 0.692 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.034203e-01 | 0.692 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.034203e-01 | 0.692 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.034203e-01 | 0.692 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.034203e-01 | 0.692 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.124331e-01 | 0.673 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 2.124331e-01 | 0.673 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 2.124331e-01 | 0.673 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.124331e-01 | 0.673 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.124331e-01 | 0.673 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.141435e-01 | 0.669 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.141435e-01 | 0.669 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.213444e-01 | 0.655 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 2.213444e-01 | 0.655 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.213444e-01 | 0.655 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.247780e-01 | 0.648 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.266136e-01 | 0.645 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.266136e-01 | 0.645 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.301555e-01 | 0.638 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.301555e-01 | 0.638 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.301555e-01 | 0.638 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.301555e-01 | 0.638 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.307826e-01 | 0.637 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.307826e-01 | 0.637 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.307826e-01 | 0.637 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.312807e-01 | 0.636 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.376231e-01 | 0.624 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.388674e-01 | 0.622 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.388674e-01 | 0.622 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.388674e-01 | 0.622 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.388674e-01 | 0.622 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.391350e-01 | 0.621 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.466090e-01 | 0.608 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.474812e-01 | 0.606 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.474812e-01 | 0.606 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.474812e-01 | 0.606 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.474812e-01 | 0.606 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.515244e-01 | 0.599 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.558800e-01 | 0.592 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.559981e-01 | 0.592 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.559981e-01 | 0.592 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.559981e-01 | 0.592 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.559981e-01 | 0.592 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.644191e-01 | 0.578 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.644191e-01 | 0.578 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.644191e-01 | 0.578 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.644191e-01 | 0.578 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.644191e-01 | 0.578 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.644191e-01 | 0.578 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.727453e-01 | 0.564 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.727453e-01 | 0.564 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.727453e-01 | 0.564 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.727453e-01 | 0.564 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.727453e-01 | 0.564 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.809778e-01 | 0.551 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.809778e-01 | 0.551 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 2.809778e-01 | 0.551 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.809778e-01 | 0.551 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.852162e-01 | 0.545 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.888944e-01 | 0.539 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.891176e-01 | 0.539 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.891176e-01 | 0.539 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.891176e-01 | 0.539 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.924696e-01 | 0.534 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.935847e-01 | 0.532 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.971657e-01 | 0.527 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.971657e-01 | 0.527 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.971657e-01 | 0.527 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.971657e-01 | 0.527 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.971657e-01 | 0.527 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.971657e-01 | 0.527 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.971657e-01 | 0.527 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.986350e-01 | 0.525 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.129911e-01 | 0.504 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.129911e-01 | 0.504 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.129911e-01 | 0.504 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.129911e-01 | 0.504 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 3.129911e-01 | 0.504 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.185978e-01 | 0.497 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.207704e-01 | 0.494 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.207704e-01 | 0.494 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.207704e-01 | 0.494 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.207704e-01 | 0.494 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.207704e-01 | 0.494 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.207704e-01 | 0.494 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.233547e-01 | 0.490 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.268931e-01 | 0.486 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.284621e-01 | 0.484 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.284621e-01 | 0.484 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.284621e-01 | 0.484 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.284621e-01 | 0.484 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.310310e-01 | 0.480 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 3.351618e-01 | 0.475 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.360672e-01 | 0.474 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.360672e-01 | 0.474 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.360672e-01 | 0.474 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.360672e-01 | 0.474 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.360672e-01 | 0.474 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.360672e-01 | 0.474 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.435866e-01 | 0.464 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.435866e-01 | 0.464 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.510213e-01 | 0.455 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.510213e-01 | 0.455 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.510213e-01 | 0.455 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.510213e-01 | 0.455 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.583722e-01 | 0.446 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.583722e-01 | 0.446 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.583722e-01 | 0.446 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.583722e-01 | 0.446 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.583722e-01 | 0.446 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.656403e-01 | 0.437 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.656403e-01 | 0.437 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 3.665857e-01 | 0.436 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.728266e-01 | 0.428 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.728266e-01 | 0.428 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.728266e-01 | 0.428 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.728266e-01 | 0.428 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.728266e-01 | 0.428 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.728266e-01 | 0.428 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.760078e-01 | 0.425 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.799319e-01 | 0.420 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 3.799319e-01 | 0.420 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.869571e-01 | 0.412 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.869571e-01 | 0.412 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.869571e-01 | 0.412 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.939031e-01 | 0.405 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.939031e-01 | 0.405 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.939031e-01 | 0.405 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.960527e-01 | 0.402 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.007709e-01 | 0.397 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.007709e-01 | 0.397 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.039891e-01 | 0.394 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.075613e-01 | 0.390 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.075613e-01 | 0.390 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.142751e-01 | 0.383 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 4.172463e-01 | 0.380 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.197116e-01 | 0.377 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.274263e-01 | 0.369 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.274766e-01 | 0.369 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.313652e-01 | 0.365 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.339660e-01 | 0.363 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.390654e-01 | 0.357 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.403822e-01 | 0.356 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.420055e-01 | 0.355 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.467260e-01 | 0.350 | 1 | 1 |
| Netrin-1 signaling | R-HSA-373752 | 4.467260e-01 | 0.350 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.467260e-01 | 0.350 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 4.529984e-01 | 0.344 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.529984e-01 | 0.344 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.529984e-01 | 0.344 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.529984e-01 | 0.344 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 4.565529e-01 | 0.341 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.592000e-01 | 0.338 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.592000e-01 | 0.338 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.592000e-01 | 0.338 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.592000e-01 | 0.338 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 4.653317e-01 | 0.332 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.655608e-01 | 0.332 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.713942e-01 | 0.327 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.773884e-01 | 0.321 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.773884e-01 | 0.321 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.949683e-01 | 0.305 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.949683e-01 | 0.305 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.949683e-01 | 0.305 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.949683e-01 | 0.305 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.949683e-01 | 0.305 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.006965e-01 | 0.300 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.006965e-01 | 0.300 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.006965e-01 | 0.300 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.063602e-01 | 0.296 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.063602e-01 | 0.296 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 5.088132e-01 | 0.293 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.119599e-01 | 0.291 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.119599e-01 | 0.291 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.174965e-01 | 0.286 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.174965e-01 | 0.286 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.174965e-01 | 0.286 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.197681e-01 | 0.284 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.229706e-01 | 0.282 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.283829e-01 | 0.277 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.283829e-01 | 0.277 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.301653e-01 | 0.276 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 5.337342e-01 | 0.273 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.337342e-01 | 0.273 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.337342e-01 | 0.273 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 5.427513e-01 | 0.265 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.442562e-01 | 0.264 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.442562e-01 | 0.264 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.442562e-01 | 0.264 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.494283e-01 | 0.260 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.494283e-01 | 0.260 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.545420e-01 | 0.256 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.545420e-01 | 0.256 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.545420e-01 | 0.256 | 1 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.545420e-01 | 0.256 | 1 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.595980e-01 | 0.252 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.595980e-01 | 0.252 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.595980e-01 | 0.252 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.604993e-01 | 0.251 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.669697e-01 | 0.246 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.702115e-01 | 0.244 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.744261e-01 | 0.241 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.798319e-01 | 0.237 | 0 | 0 |
| Translation | R-HSA-72766 | 5.819781e-01 | 0.235 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.887576e-01 | 0.230 | 1 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.887576e-01 | 0.230 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.887576e-01 | 0.230 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.887576e-01 | 0.230 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.887576e-01 | 0.230 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.887576e-01 | 0.230 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.934273e-01 | 0.227 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.934273e-01 | 0.227 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.980442e-01 | 0.223 | 1 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.980442e-01 | 0.223 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.026090e-01 | 0.220 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.026090e-01 | 0.220 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.071223e-01 | 0.217 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.115845e-01 | 0.214 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.137553e-01 | 0.212 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.159964e-01 | 0.210 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.246711e-01 | 0.204 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 6.289351e-01 | 0.201 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.331509e-01 | 0.198 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.373191e-01 | 0.196 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.414401e-01 | 0.193 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.495431e-01 | 0.187 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.535260e-01 | 0.185 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.574639e-01 | 0.182 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.574639e-01 | 0.182 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.574639e-01 | 0.182 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.593188e-01 | 0.181 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.613573e-01 | 0.180 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 6.613573e-01 | 0.180 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.652067e-01 | 0.177 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.690125e-01 | 0.175 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.764956e-01 | 0.170 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.874059e-01 | 0.163 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.874059e-01 | 0.163 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 6.891235e-01 | 0.162 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.909607e-01 | 0.161 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.931045e-01 | 0.159 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.047824e-01 | 0.152 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.047824e-01 | 0.152 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.047824e-01 | 0.152 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.114609e-01 | 0.148 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.114609e-01 | 0.148 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.114609e-01 | 0.148 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.179891e-01 | 0.144 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.243705e-01 | 0.140 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 7.275071e-01 | 0.138 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.306082e-01 | 0.136 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.367054e-01 | 0.133 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.397024e-01 | 0.131 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.426655e-01 | 0.129 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.455950e-01 | 0.127 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.455950e-01 | 0.127 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.455950e-01 | 0.127 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.484913e-01 | 0.126 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.569850e-01 | 0.121 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.569850e-01 | 0.121 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.597523e-01 | 0.119 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.678677e-01 | 0.115 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.731259e-01 | 0.112 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.731259e-01 | 0.112 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.757104e-01 | 0.110 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.798460e-01 | 0.108 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.807919e-01 | 0.107 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.807919e-01 | 0.107 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.807919e-01 | 0.107 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.857589e-01 | 0.105 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.882003e-01 | 0.103 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.882003e-01 | 0.103 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.930003e-01 | 0.101 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.999982e-01 | 0.097 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.257139e-01 | 0.083 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 8.296679e-01 | 0.081 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.316113e-01 | 0.080 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.334132e-01 | 0.079 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.348754e-01 | 0.078 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.481389e-01 | 0.072 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.498727e-01 | 0.071 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.566130e-01 | 0.067 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.614700e-01 | 0.065 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.669099e-01 | 0.062 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 8.669099e-01 | 0.062 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.676923e-01 | 0.062 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.748348e-01 | 0.058 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.793152e-01 | 0.056 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.847400e-01 | 0.053 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.860579e-01 | 0.053 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.886488e-01 | 0.051 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.886488e-01 | 0.051 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.948726e-01 | 0.048 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.018861e-01 | 0.045 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.063012e-01 | 0.043 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.115431e-01 | 0.040 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.211680e-01 | 0.036 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.247195e-01 | 0.034 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.339543e-01 | 0.030 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.422613e-01 | 0.026 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.442266e-01 | 0.025 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.467440e-01 | 0.024 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.485576e-01 | 0.023 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.530990e-01 | 0.021 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.643106e-01 | 0.016 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.672320e-01 | 0.014 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.862647e-01 | 0.006 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.918768e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.948177e-01 | 0.002 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.989440e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998970e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999020e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999998e-01 | 0.000 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Down-Regulation | R-HSA-8849472 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Expression | R-HSA-8849473 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.000000e+00 | 0.000 | 1 | 1 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
